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Zusammenfassung
Die Arbeit, die in dieser Dissertation vorgestellt wird, besteht aus drei unabhängige Teilen. Die Teile I
und III sind durch das Thema des Ursprungs des Lebens verbunden. Die Teile II und III basieren auf der
gleichen biophysikalischen Analysemethode der Mikrothermophorese (MST).
Teil I konzentriert sich auf die präbiotische Replikation von DNA. Verschiedene Ansätze zur Rep-
likation von RNA und DNA unter präbiotischen Bedingungen werden in der Einführung diskutiert. Ein
nonenzymatisches DNA-Replikationssystem wird als einer der möglichen Ansätze für einen präbiotis-
chen Replikator vorgestellt. Zwei DNA-Stränge mit 24 Basen kreuz-katalysieren die gegenseitige Syn-
these aus vier 12 Basen langen Substratsträngen, von denen zwei in situ durch ein Kondensationsmittel
1-ethyl-3-(3-dimethylamino-propyl)carbodiimid (EDC) aktiviert werden. Eine (2.2 ± 0.5)-fache Am-
plifikation wird in 6 Stunden erreicht. Eine stärkere Amplifikation wird durch EDC-induzierte Mod-
ifikation von Substratsträngen unterdrückt. Ein detailliertes kinetisches Model, das die Modifikation-
skinetik berücksichtigt, wurde mit einem System von gewöhnlichen Differentialgleichungen realisiert
und erlaubte es, kritische Parameter der Reaktion zu verstehen. Weitere Forschungsarbeiten sollten
sich darauf konzentrieren, Wege zu finden, wie das Substrat wiederverwendet werden kann oder wie
seine Modifikation reduziert werden kann. Dies könnte zu DNA-Replikations- und Verlängerungsex-
perimenten führen, die von kurzen zufälligen DNA-Strängen ausgehen. Solche Experimente könnten
mit next-generation Sequenzierung analysiert werden, da die nativen Phosphodiesterbindungen an den
Bindungsstellen entstehen.
In Teil II wird MST verwendet, um einen diagnostischen Assay für α-Antitriypsin (AAT)-Mangel
zu entwickeln, der direkt im Blutplasma funktioniert. Bei AAT-Mangel haben Einzelpersonen eine re-
duzierte Plasmakonzentration von AAT, was sie unter anderem anfällig für Lungenemphyseme macht.
Überraschenderweise korreliert die Konzentration von AAT nicht mit dem Ausmass der Symptome. Bei
einem Standard-MST-Ansatz ist die Amplitude der erhaltenen Bindungskurve für die Affinitätsanalyse
nicht wichtig. In einem in dieser Arbeit vorgestellten MST-basierten kompetitiven Assay hängt die Am-
plitude der erhaltenen Bindungskurve sowohl von der Affinität der AAT-Bindung an ihr Target als auch
von der Konzentration von AAT ab. In einem Proof-of-Principle-Experiment wurde das Blutplasma von
Individuen mit AAT-Mangel zur Quantifizierung der Amplitude verwendet. Die Amplitude zeigte eine
bessere Korrelation mit dem Ausmaß des Krankheitszustandes als die Konzentration von AAT allein,
was darauf hindeutet, dass die Affinität von AAT zu seinem Target bei verschiedenen Individuen unter-
schiedlich ist. Die direkte Messung der AAT-Affinität zu ihrem Target im Plasma von Individuen mit
starker vs. schwacher Manifestation der Symptome zeigte, dass die Affinität bei Individuen, die nur le-
icht betroffen waren, höher war. Dies deutet darauf hin, dass die Plasmazusammensetzung einen Einfluss
auf die AAT-Affinität hat.
In Teil III werden experimentelle Systeme entwickelt, um die stereochemische Theorie der Herkunft
des genetischen Codes zu testen. Der genetische Code definiert die Zuordnung von 20 Aminosäuren
zu ihren Codons. Die Hypothesen darüber, was die Zuordnung bestimmt hat, wurden in der Liter-
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atur ausführlich diskutiert, aber die Frage bleibt eine der experimentell anspruchsvollsten im Bereich
des Ursprungs des Lebens. Die stereochemische Theorie besagt, dass Aminosäuren eine intrinsis-
che Bindungsaffinität zu ihren Codons haben. Dies kann durch direkte Messung der Wechselwirkung
zwischen den aktivierten Aminosäuren und codonhaltigen RNA-Strukturen getestet werden. Auf der
Grundlage der Literaturrecherche wurden RNA-Strukturen entwickelt und die Affinität mit der MST-
Methode gemessen. Proof-of-Principle-Experimente für drei RNA-Strukturen wurden durchgeführt, und
ein Ansatz für die zukünftige Arbeit wird am Ende detailliert diskutiert.
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Abstract
The work presented in this Thesis is divided into three independent parts. Parts I and III are connected
by the topic of the Origin of Life. Parts II and III are based on the same biophysical analysis method of
microscale thermophoresis (MST).
Part I focuses on prebiotic replication of DNA. Different approaches to replicate RNA and DNA
under prebiotic conditions are discussed in the introduction. A nonenzymatic DNA replication system is
presented as an approaches to a prebiotic replicator. Two DNA strands of 24 bases cross catalyze each
other’s synthesis from four 12 bases long substrate strands, two of which are in situ activated by a con-
densing agent 1-ethyl-3-(3-dimethylamino-propyl)carbodiimide (EDC). DNA amplified (2.2 ± 0.5)-fold
in 6 hours. Stronger amplification is suppressed by EDC-dependent modification of substrate strands.
Detailed kinetic modeling was realized with the system of ordinary differential equations and allowed
to understand critical parameters of the reaction. Further research should be focused on finding ways
to recycle substrate or to reduce its modification. This could lead to DNA replication and elongation
experiments starting from short random DNA strands. Such experiments could be analyzed with next-
generation sequencing due to the formation of the natural phosphodiester bonds at the ligation sites.
In part II, MST is used to develop a diagnostic assay for α1-antitriypsin (AAT) deficiency disorder
working directly in blood plasma. In AAT deficiency, individuals have reduced plasma concentration of
AAT, which makes them susceptible to lung emphysema among other symptoms. Surprisingly, concen-
tration of AAT does not correlate with the severity of the symptoms manifestation. In a standard MST
approach, the amplitude of the obtained binding curve is not important for the affinity analysis. In an
MST-based competition assay introduced in this work, the amplitude of the obtained binding curve is
sensitive to both the affinity of AAT binding to its target and the concentration of AAT in plasma. In
a proof-of-principle experiment, blood plasma of individuals with AAT deficiency was used to quantify
the amplitude. The amplitude showed a better correlation to the severity of the disease status than the
concentration of AAT alone, suggesting that AAT affinity to its target is different in different individuals.
Direct measurement of AAT affinity to its target in plasma of individuals with strong vs weak manifes-
tation of symptoms showed that affinity was higher in individuals who were only mildly affected. This
suggests that plasma composition has an effect on AAT affinity.
In part III, experimental systems are developed in order to test the stereochemical theory of the origin
of the genetic code. The genetic code defines the assignment of 20 amino acids to their codons. The
hypotheses to what determined the assignment have been widely discussed in literature but the question
remains one of the experimentally most challenging in the origin of life field. The stereochemical theory
states that amino acids have an intrinsic binding affinity towards their cognate codons. This can be tested
by directly measuring the interaction between the activated amino acids and RNA structures containing
codons. RNA structures were developed based on literature research, and the affinity was measured with
the MST method. Proof-of-principle experiments for three RNA structures were performed, and the
outline for future work is detailed in the end.

CONTENTS CONTENTS
Contents
I Nonenzymatic cross-replication of DNA strands 11
1 Motivation and Introduction 12
2 Experimental Procedures and Data Analysis 16
2.1 Materials . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16
2.2 General reaction procedure . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16
2.3 Reaction analysis method . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17
2.4 Acquisition of melting curves . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19
2.5 Quantification of the dissociation rates . . . . . . . . . . . . . . . . . . . . . . . . . . . 19
2.6 Simulation and data fitting . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19
3 Results 20
3.1 Experimental realization of the replication system . . . . . . . . . . . . . . . . . . . . . 20
3.2 Characterization of fragment modification . . . . . . . . . . . . . . . . . . . . . . . . . 25
3.3 Kinetic description and simulations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27
4 Discussion and Outlook 35
II Development of an assay to diagnose α1-antitriypsin deficiency disorder in blood
plasma 39
5 Motivation and Introduction 40
5.1 A typical MST experiment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 42
5.2 Technical extensions of a typical MST experiment . . . . . . . . . . . . . . . . . . . . . 45
5.3 Literature overview of the bioanalytical applications of MST . . . . . . . . . . . . . . . 46
6 Theoretical Considerations 51
7 Experimental Realization 55
7.1 Experimental Procedures and Data Analysis . . . . . . . . . . . . . . . . . . . . . . . . 55
7.2 Assay development . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 58
7.3 Amplitude and disease status . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 60
7.4 Sensitivity of Z-variant AAT to plasma environment . . . . . . . . . . . . . . . . . . . . 61
8 Discussion and Outlook 62
5
CONTENTS CONTENTS
III Stereochemical theory of the origin of the genetic code 65
9 Motivation and Introduction 66
10 Experimental Realization 71
10.1 Materials and Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 71
10.2 Results and Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 72
11 Outlook 76
Acknowledgments 89
A Associated First Author Publications 91
6
List of Figures
1 ssDNA analysis with Bioanalyzer gel electrophoresis. . . . . . . . . . . . . . . . . . . 18
2 Replication system and detection. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21
3 Replication by ligation. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22
4 Control reaction in the absence of 3′-phosphate groups on the corresponding fragments. 23
5 Effect of fragment modification on the ligation rate. . . . . . . . . . . . . . . . . . . . 24
6 Fragment peaks on the gel electrophoresis traces, and 3′-phosphate group-dependent
fragment modification. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 26
7 Determination of rates for the simulation. . . . . . . . . . . . . . . . . . . . . . . . . . 28
8 Simulation of the ligation reaction and fit of the experimental data. . . . . . . . . . . . 31
9 Simulation of the effect of the reaction rates modulation on the ligation reaction outcome. 36
10 A typical MST experiment. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 44
11 Dependency of the amplitude on the AAT concentration and the dissociation constant of
NE-AAT binding. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 59
12 Amplitude, but not plasma concentration of AAT correlates with disease severity. . . . . 60
13 Plasma-dependent change in affinity of NE-AAT binding. . . . . . . . . . . . . . . . . 61
14 Z-variant AAT is more susceptible to plasma-dependent changes than AAT without Z-
mutation. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 62
15 Functional differences between two M1 AAT variants in lipid-containing vs in lipid-free
plasma. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 63
16 The genetic code and the tRNA. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 66
17 Structures used for analyzing binding affinities. . . . . . . . . . . . . . . . . . . . . . . 69
18 Preliminary affinity measurements between the AMP-binding aptamer and AMP, Gly, or
aa-AMP ligands. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 72
19 Preliminary tests of the Rodin’s hypothesis. . . . . . . . . . . . . . . . . . . . . . . . . 73
20 Preliminary tests of the Hopfield’s hypothesis. . . . . . . . . . . . . . . . . . . . . . . 74
21 AMP and Val-AMP in the binding pocket of the AMP-binding RNA aptamer. . . . . . . 77

List of Tables
1 Reaction conditions and amplification factors for BA/ab motifs in four reactions. . . . . 23
2 Two sets of rate constants that model temperature cycling in the system without and with
modification (normal and bold terms). . . . . . . . . . . . . . . . . . . . . . . . . . . . 30
3 ODEs describing the experimental system without and with modification (normal and
bold terms). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 32
9

Part I
Nonenzymatic cross-replication of DNA strands
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1 MOTIVATION AND INTRODUCTION
1 Motivation and Introduction
According to a current NASA definition of life, life is “a self-sustaining chemical system capable of
Darwinian evolution”. To be able to undergo Darwinian evolution, a living system has to be able to
reproduce, and reproduction is based on the ability of the system to encode and transfer information
through generations. The replication of information-carrying polymers (DNA and RNA) is central to
this process. In modern organisms, the replication of DNA depends on complex proteins called enzymes.
However, enzymes themselves are encoded in the DNA. This poses a well-known chicken and the egg
problem of the origin of life: what came first, complex proteins or DNA? It seems unlikely, however,
that enzymes were present early in evolution. Therefore, research has been focused on finding enzyme-
independent pathways to replicate DNA-like polymers. Of high importance is to find pathways simple
enough to be plausible on early Earth.
Base-by-base replication by a ribozyme One of the widely popular hypothesis, coined the “RNA
world” hypothesis, suggests that life initially was RNA based. RNA molecules on the prebiotic Earth,
apart from storing information, could have catalyzed their own replication [6, 24, 61, 98]. And indeed
RNA molecules, called ribozymes, are known to be able to catalyze reactions. To prove that RNA
can catalyze its own replication, researchers have been developing polymerase ribozymes that mimic
polymerase enzymes in that they could catalyze RNA replication in a base-by-base fashion.
The best base-by-base polymerase ribozyme developed to date can synthesize a variety of functional
RNAs, including aptamers and other ribozymes [31]. Although, the polymerase ribozyme was shown to
extend strands through difficult sequence features and to copy strands of 35-40 bases long to full length
and in good yield, synthesis of longer sequences remains challenging. The longest structure synthesized
by this polymerase was a tRNA molecule of 76 bases, however, in a very low yield. The synthesis of the
180 bases long polymerase ribozyme itself remains a non-resolved task.
Apart from a ribozyme-catalyzed replication by polymerization of monomers, ribozyme-catalyzed
replication by successive polymerization of short oligonucleotides was also studied. Just recently, an in
vitro evolved ribozyme was shown to successfully replicate structured RNA motifs starting from trimer
oligonucleotide substrates instead of monomers [1]. Although 240-times slower than the most advanced
base-by-base polymerase ribozyme discussed above, the triplet polymerase achieved a comparable fi-
delity and allowed to copy through difficult previously unaccessible regions of structured RNA. Replica-
tion of the triplet polymerase ribozyme itself was only achieved by segmenting the sequence into shorter
sequences and resulted in low efficiencies of both synthesis and final assembly.
A base-by-base polymerase ribozyme able to copy a sequence longer than itself (206 nt sequence by
a 202 nt-long ribozyme) was reported [2], however, it posed strong sequence limitations on the primer,
from which it was able to start the polymerization reaction. It preferred C-rich sequences, absence of
secondary structures, and reduced G-content, among others. Such limitations meant that copying of both
“-” and “+” strands of its own sequence was impossible, and, thus, an exponential amplification of the
polymerase ribozyme required for Darwinian evolution experiments was also impossible.
12
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The work on triplet polymerase ribozyme stressed the importance of considering different substrates
for replication than just monomers. Interestingly, it was discussed that conditions promoting rather than
disfavoring base-pairing led to the ability of the ribozyme to copy through difficult structural motifs. The
utilization of triplets resulted in lower entropic costs per binding position and cooperative invading effects
that helped in unwinding the structured RNA motifs. Extra stability also came from the intra-triplet
base stacking interactions. Low temperature conditions and high solute concentrations from working in
eutectic ice phase aided in increasing the base pairing stability. Replication by polymerization of short
oligonucleotides should be considered alongside the canonical base-by-base replication.
Ribozyme that achieved exponential replication-by-ligation None of the above systems was capa-
ble of exponential amplification. An exponential amplification was achieved by a different kind of a
ribozyme, a ligase that catalyzed replication through ligation of two substrate strands [47]. The product
of ligation was another ligase ribozyme that could in turn ligate two different substrate strands to pro-
duce the initial ligase ribozyme. Thus, the system was replicating in a cross-catalytic fashion and could
amplify exponentially. An exponential amplification behavior allowed the authors to perform selection
experiments starting from the population of slightly mutated ligases. However, the dependence of the
system on the preformed long substrate strands of a specific composition has a major drawback: evolu-
tion from random pools of short oligonucleotides as well as open-ended evolution are not allowed in this
ligase-based system.
Nonenzymatic replication Although it is an impressive achievement of science that ribozyme poly-
merases are routinely used in labs today, the fact that none of them can reproduce their own sequences
in good yield to allow Darwinian evolution experiments suggests that less complex (though not less dif-
ficult to realize in lab) nonenzymatic mechanisms could have been at work early in evolution. These
mechanisms should have been able to replicate and elongate short random oligonucleotides present on
prebiotic Earth. To this end, ribozyme-free approaches to replication were also considered in literature
on prebiotic DNA/RNA replication.
One approach is to use activated substrate monomers or oligomers that, upon base pairing with the
template, can ligate to the primer or to each other releasing a leaving group that was storing the activation
energy. For example, monomers pre-activated with a 2’-methylimidazol leaving group were shown to
polymerize in a base-by-base fashion on an RNA template starting from a primer, when supported by
activated trimers binding downstream of the reaction site [66]. Since trimers were activated with the same
leaving group as monomers, it is not surprising that also ligation of these helper oligonucleotides was
observed in the same reaction pot. Thus, here again, we see an advantage of using different substrates
for replication: monomers and trimers.
In all of the above base-by-base replication experiments, the primary goal was to achieve polymer-
ization leading to replication of the template. However, for Darwinian evolution experiments, replication
of the template should be followed by replication of the product to gain a new molecule of the initial
13
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template, similar to a PCR reaction. This - over many cycles - would lead to an exponential amplification
of the initial template and could drive sequence evolution through random mutations.
A replication scheme, where initial template catalyzes the synthesis of a molecule of its complement,
and then the complement catalyzes the synthesis of the new molecule of the initial template, is called a
cross-catalytic scheme. On the other hand, if the initial template is self-complementary, its complement
will be an initial template itself. Such a replication scheme is called an autocatalytic scheme.
Replication of a short self-complementary DNA strand by ligation of two shorter complementary
strands was studied by the Kiedrowski group. They used chemical ligation catalyzed by a 1-ethyl-3-(3-
dimethylamino-propyl)carbodiimide (EDC) under isothermal conditions [93]. In the reaction presented
by the Kiedrowski group in 1986, two DNA trimers condensed in a template-directed fashion to form
a hexamer oligonucleotide that served as a new template molecule. In the following work by the same
group, a substitution of a 5′-hydroxyl group for a 5′-amino group at the ligation site significantly in-
creased the efficiency of the ligation reaction [94]. However, this strategy led to a formation of a phos-
phoramidate bond instead of the naturally occurring phosphodiester bond at the ligation site and, thus,
resulted in a product with heterogenous bonds. Independent of the type of bond formed at the ligation
site, the product concentration saturated, presumably as a result of product inhibition.
The problem of product inhibition In product inhibition, self-complementary product strands form
stable duplex complexes, thereby inhibiting the next reaction. To overcome product inhibition and to
drive exponential amplification of longer strands, temperature cycling can be introduced to melt product
duplexes and allow their reuse as templates. Conditions of temperature cycling on early Earth could have
been present e.g. in the form of temperature gradients across porous rocks of hydrothermal vents deep
in the oceans or hydrothermal fields with geysers.
Carbodiimides Carbodiimides, such as EDC, have been optimized for efficient condensation of car-
boxylic acids with nucleophilic amines. While they can also be used for the condensation of weaker
nucleophiles, like carboxylic acids or pyrophosphates [43], these reactions suffer from an unwanted side-
reaction as a consequence of the relatively low nucleophilicity. In the side reaction, the O-acylisourea
intermediate rearranges into the stable non-reactive N-acylurea [80]. Therefore, side products are also
expected in EDC-driven condensation of oligonucleotides. However, the high speed of ligation could
compensate for the amount of modifications.
Although a prebiotic pathway for EDC synthesis has not been suggested, it shares its reactive group
with a tautomer of cyanamide – a molecule presumably formed under prebiotic conditions [77, 90].
Project goal The goal of this project was to establish and characterize an exponential cross-catalytic
DNA replication system. For this I aimed to:
• design a cross-catalytic DNA replication system with the following characteristics:
14
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– replication should be nonenzymatic, template-driven, occur by ligation of shorter comple-
mentary oligonucleotide fragments, and lead to the formation of a product with the native
backbone;
• employ temperature cycling in order to overcome product inhibition;
• establish protocols for serial dilution (in order to mimic environmental selection pressure) and
feeding (in order to provide the reaction with fresh fragments for ligation);
• realize a detailed kinetic model of the system by solving a system of ordinary differential equations
(ODEs) and use it to understand and fit experimental data.
15
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2 Experimental Procedures and Data Analysis
2.1 Materials
Buffers
Control buffer: 100 mM MOPS at pH 6.5, adjusted with NaOH. Reaction buffer: 400 mM EDC freshly
dissolved in the control buffer. MOPS was purchased from Sigma Life Science (M1254-100G) and EDC-
HCl was purchased from Carl Roth GmbH (Art.-Nr. 2156.2). Only nuclease-free water from Ambion
(AM9932) was used in all experiments.
DNA oligonucleotides
All DNA oligonucleotides were purchased from biomers.net GmbH with HPLC purification. The se-
quences were as follows. Template BA: TTT ATT ATT TTA TAT TAT TTA TTT, template ab: AAA
TAA ATA ATA TAA AAT AAT AAA, replicate ~BA: CCC TTT ATT ATT TTA TAT TAT TTA TTT,
replicate ~ab: CCC CCC CCC AAA TAA ATA ATA TAA AAT AAT AAA, fragment ~B: CCC TTT
ATT ATT TTA (with or without a 3′-phosphate group for reaction or control experiments), fragment b:
TAA AAT AAT AAA, fragment A: TAT TAT TTA TTT, fragment ~a: AAA TAA ATA ATA (with or
without a 3′-phosphate group for reaction or control experiments), normalization strand: TAG TTA TGT
CGA TAC GAG ACA ACA CCA TAT GCA TTT AAG TCG CTT GAA ATT GCT ATA AGC AGA
GCA CTC GTA TCG ACA TAA CTA.
2.2 General reaction procedure
The DNA was mixed on ice at 1:1 ratio with the 2x reaction buffer in a maximum recovery PCR tube
(Axygen, brand of Corning Life Sciences). Promptly, the tube was placed in a qTower3G cycler (Ana-
lytik Jena AG) at 20 ºC to start temperature cycling (with 8 ºC/sec heating rate, 6 ºC/sec cooling rate).
For serial dilution, the cycler was paused 2 seconds before the end of the corresponding 20 ºC step and
the tube was placed on ice. 10% of the reaction volume was precipitated for analysis and the volume was
replaced with 5% volume of the fragment mix in water (each fragment at 20x its initial concentration)
and with another 5% volume of the 2x reaction buffer. The tube was promptly placed back in the cy-
cler, and the cycler program was continued. At the end of the reaction run time, the full sample volume
was precipitated. The standard ethanol precipitation [70] was performed but with addition of 2 µl (for a
sample volume of 30 µl) of glycogen (10 mg/ml), which is known to enhance the precipitation of short
oligonucleotides. The DNA was allowed to precipitate overnight at 4 ºC before centrifugation, cleaning
the pellet with 70% ethanol, and air-drying it.
16
2 EXPERIMENTAL PROCEDURES AND DATA ANALYSIS 2.3 Reaction analysis method
2.3 Reaction analysis method
Precipitated samples were redissolved in x/50∗v volume of water, where x is the initial concentration of
one of the templates and v is the volume of the sample used for precipitation. The samples were loaded
onto the Bioanalyzer chip (Agilent Small RNA Kit) and the Bioanalyzer assay was performed according
to the company’s protocol.
Quantification of Bioanalyzer curves
The Bioanalyzer instrument provides an automated gel electrophoresis system running on a microfluidic
chip. Per chip, a maximum of 12 samples could be analyzed. Although the Agilent Small RNA Kit
was designed for detection of short RNA strands (6-150 nt), in this work a procedure for detection and
quantification of short ssDNA strands (~10-100 nt) was established.
The full-timescale fluorescence traces of the example reaction (reaction is introduced in Section 3.1)
and calibration samples are shown in Figure 1a. The area and position of the peak that belongs to a
specific strand depends on its length, sequence, and present modifications (e.g. the 3′-phosphate group).
Thus, calling the peaks of the reaction traces required studying traces of samples composed of various
species combinations.
Calibration experiments showed that the area of the peak was proportional to the ssDNA strand
concentration (Figure 1c). Using this, the concentrations of the templates and the emerging products
were calculated from the two calibration traces ran on the same Bioanalyzer chip. The two calibration
traces included a template or its complement and both product strands with the known concentration of
50 nM each (Figure 1b). Due to a varying gel/dye composition and subsequently slightly varying strength
of the fluorescence signal between Bioanalyzer chips, the two calibration samples were included in every
run.
In addition, a slight fluorescence signal variation between different wells of the same Bioanalyzer
chip was observed. According to the company protocol, a commercially available “marker solution”
with a known strand used for normalization should exclude this fluorescence variation. However, the
marker strand overlaid with some of the fragment peaks and could not have been used as a fluorescence
control in the analysis of the system from this project (Figure 1a). Instead, a 84 nt-long DNA strand was
included as a normalization strand.
Quantification with the Agilent Bioanalyzer instrument established in this paper for ssDNA allowed
to quantify many samples in a parallelized fashion using minimal amount of material per analysis (1 µl
of 50 nM concentrated DNA strand per sample), roughly 100 times less than with HPLC.
Error quantification
To quantify the error that analysis on the Bioanalyzer instrument yielded, a control experiment was
performed, where in addition to the marker solution, the same sample consisting of one template, two
products, and the normalization strand was pipetted into every well. It showed that the area normalization
17
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Figure 1: ssDNA analysis with Bioanalyzer gel electrophoresis.
As introduced in Section 3.1, ab and BA represent templates, ~ab and ~BA represent products of ligation,
~B, A, b, and ~a represent oligonucleotides that undergo templated ligation. (a) Full-timescale fluores-
cence traces of the reaction samples at 0 and 1 hours (solid lines) and calibration samples (dashed lines)
from the microfluidic gel electrophoresis from Bioanalyzer. Calibration traces contained each strand at
a fixed concentration of 50 nM and were required for quantification of the reactions. The normalization
strand was included in each sample to correct for the fluorescence differences between different wells
of the Bioanalyzer chip. A marker is used in standard Bioanalyzer applications instead of the additional
normalization strand. In this work, the marker was not included, because the marker peak overlaid with
some of the fragment peaks. (b) Zoom into the calibration traces (dashed lines) with additional Gaussian
function fits (solid red lines). To facilitate the analysis of the products of the reaction, the 3 nt- and
9 nt-long 5′-polycytidine tags were included in the fragments ~B and ~a, respectively. This allowed to
separate the products from the templates and individually quantify each product. Since the peaks of the
two templates overlaid, two calibration samples were included in every Bioanalyzer run. The area of
each peak was quantified by fitting a Gaussian function. (c) The increase in the peak area with the strand
concentration showed a linear dependence for each template and product strand. Beyond 400 nM, a non-
linear dependence was observed and, therefore, the concentrations used in the analysis with Bioanalyzer
were kept below this value.
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between the curves of different wells could be performed by normalizing either to the peak area of the
marker strand or to the peak area of the normalization strand introduced by us. The well-to-well error
left after the normalization was 10%, which corresponds to the pipetting error. The 10% pipetting error
was thus included as the predominant error source in the results.
2.4 Acquisition of melting curves
Melting curves were measured in a C1000TM Thermal Cycler with a CFX96TM detection system (Bio-
Rad Laboratories) at a rate of 0.083 ºC/sec in either the control buffer or the reaction buffer. Eva Green
dye (Biotium Inc.) was used at a 1x concentration for detection. Templates and replicates were measured
at 1 µM concentration each, while all fragments were measured at 10 µM concentration each.
2.5 Quantification of the dissociation rates
Each melting curve was baseline corrected and normalized to depict the fraction of bound strands on the
y-axis. The association constant, Ka, was quantified from the Arrhenius plot following the description
in literature [56], using an in-house written LabVIEW routine (LabVIEW 2010, National Instruments).
The dissociation rate, ko f f , was then quantified from Ka = kon/ko f f , where the association rate, kon
(0.4 µM−1s−1), was taken from literature [62, 104].
2.6 Simulation and data fitting
The ODEs were solved in MATLAB using the solver ode15s. The experimental data was fitted with the
lsqcurvefit tool with kmod (introduced later in Section 3.3) as a single fit parameter.
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3.1 Experimental realization of the replication system
Experimental system
The initial mix of the experimental system (Figure 2a) consisted of two 24 bases-long DNA templates
ab and BA and four shorter complementary DNA fragments A (12 bases), ~B (15 bases, with 12 binding
to ab), b (12 bases), and ~a (21 bases, with 12 binding to BA). The templates were comprised only
of adenine and thymine nucleobases and were designed to prevent interstrand hairpin formation. The
base composition was limited to adenine and thymine only, in order to limit the sequence space for
potential future projects when short random oligonucleotides could be analyzed (addressed in more detail
in Section 4 “Discussion and Outlook”). The strands ~a (tagged a) and ~B (tagged B), apart from having
parts complementary to the templates, also contained polycytidine tails at the 5′-ends important as tags
for the detection with electrophoresis, and phosphate groups at the 3′-ends necessary for the ligation
reaction.
When EDC was added to the initial mix, a nonenzymatic ligation of the fragments on the correspond-
ing templates occurred (“Initial Ligation” in Figure 2a), producing the tagged replicates ~BA (27 bases
with a 3nt tag) and ~ab (33 bases with a 9nt tag). Tagging the replicates with polycytidine tails allowed
to distinguish products of the ligation reaction from the templates on the microfluidic gel electrophoresis
Bioanalyzer instrument as explained in Section 2.3. Importantly, the reaction led to the formation of nat-
ural phosphodiester bonds at the ligation site. Once the replicates formed, they were cross-catalytically
replicated through cycles of melting and annealing/ligation (“Replication” in Figure 2a).
Reaction conditions
The reaction was performed in the reaction buffer: 400 mM EDC freshly dissolved in 100 mM MOPS
at pH 6.5. Under these conditions, EDC has a half-life in the range of tens of hours [89, 97, 100]. The
reaction was cycled between 20°C for 0.5 hours and 65°C for 1 second. Additionally, every hour, 10%
volume of the reaction was exchanged for a fresh solution of a fragment mix (b, ~a, ~B, and A) and
EDC (Figure 2b). This step is further referred to as a feeding/dilution step, the goal of which was to
apply an environmental pressure through an exponential dilution of the templates but at the same time
to continuously provide the reaction with “food” for sustained replication. The EDC concentration was
kept constant while the fragment concentration was increasing with each feeding step. I allowed the
reactions to run for a total of up to 6 hours.
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Figure 2: Replication system and detection.
(a) When templates were mixed with fragments and EDC at 20°C, an initial ligation occurred that formed
the replicates ~BA and ~ab. Once the replicates were released from the templates during the melting
step (not shown), both replicates could be further exponentially amplified. (b) The reaction was cycled
between 20° C for 0.5 hours and 65°C for 1 second with the heating and cooling rates of 8 and 6 °C/sec,
respectively. Every hour (black star and arrow), 10% of the reaction volume was replaced with 10%
of the fragment mix in the reaction buffer. The original templates were thereby actively diluted, while
the new fragments were available for the reaction. (c) Templates and tagged replicates separated on the
microfluidic gel electrophoresis chip allowing individual quantification. Reactions were started with 1
µM of each template and 10 µM of each fragment in the reaction buffer and were stopped after 0, 1, 2, 4,
and 5 hours. Over the course of the reaction, the template peak was decreasing due to the serial dilution,
while the replicate peaks were increasing despite the serial dilution.
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Figure 3: Replication by ligation.
Concentration of replicates from Figure 2c was quantified for the total ab and BA motifs (light and
dark blue circles). The solid blue line shows the full kinetic simulation of the system (introduced in
Section 3.3). The solid black line documents the calculated concentration of each template considering
the dilution steps. The inset shows time points taken within the first hour and the simulation result for
the first hour.
Surviving replicator
The reaction progression was monitored on the Bioanalyzer instrument. Quantification of the replicate
concentrations required to
• fit a Gaussian function to each peak to obtain peak areas for each curve,
• normalize each curve to a peak area of an internal control strand, and
• calculate concentrations from peak areas, using peak areas of calibration curves that contained
known concentrations of template and product strands as references (refer to Section 2.3 for more
detail).
A consistent increase of replicate concentration in the reaction was observed while templates were being
diluted out (Figure 2c, Figure 3). As a control, a reaction was initiated with 3′-dephosphorylated frag-
ments ~a and ~B. As expected, no product was formed after 5 hours of monitoring the reaction, because
a condensation reaction could not occur without a phosphate group at the ligation site (Figure 4).
In each experiment, the amplification factor was quantified separately for BA and ab motifs as
ABA = ct=∆t∼BA+BA/c
t=0
BA and Aab = c
t=∆t
∼ab+ab/c
t=0
ab , where ABA and Aab are the amplification factors for BA
and ab, ct=∆t
∼BA+BA is the BA concentration originating from template BA and the replicate ~BA at the end
of the reaction (ct=∆t
∼ab+ab represents the same for the ab concentration), and c
t=0
BA is the BA concentration
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Figure 4: Control reaction in the absence of 3′-phosphate groups on the corresponding fragments.
The gel electrophoresis traces in the presence (dashed lines) and absence (solid lines) of the 3′-phosphate
groups. As expected, no replicates were formed in the absence of the 3′-phosphate group, since the
condensation reaction between the 3′- and the 5′-ends of the corresponding fragments could not occur.
Here, the area of the first peak of the 5-hour control reaction trace (solid orange line) is large because
the peak of the ~a fragment without a phosphate group overlaid with the template peaks ab and BA. The
area increase resulted from the hourly feeding of the ~a fragment.
originating only from the template at the start of the reaction (ct=0ab represents the same for the ab concen-
tration). The average amplification factor and its standard deviation were obtained from four different
experiments where individual amplification factors for BA and ab were calculated (Table 1). Variation
in the precipitation yields and pipetting errors are the likely sources of discrepancies between the am-
plification factors in different experiments. Taken together, this resulted in amplification fold for each
template of 2.2 ± 0.5 within 6 hours. The original templates, meanwhile, were diluted such that 59% of
the original templates was left after 6 hours (Figure 3).
Table 1: Reaction conditions and amplification factors for BA/ab motifs in four reactions.
Exp Nr. ct=0BA (µM) c
t=0
ab (µM) ∆t (hrs) ABA Aab
1 1 1 6 2.12 2.08
2 0.7 0.7 6 1.52 1.66
3 0.5 0.5 6 2.36 3.03
4 1 1 5 2.21 2.44
Both products were found to replicate symmetrically (dark and light blue marker points in Figure 3).
The sequences for this reaction were chosen to have a symmetric ligation site on both sides: . . . TA-3′-
PHO at the 5′-end ligating to 5′-TA. . . at the 3′-end.
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Figure 5: Effect of fragment modification on the ligation rate.
(a) Fragments were incubated in the reaction buffer under the temperature cycling conditions. A decrease
in the signal from the phosphorylated fragments was observed and a shoulder formed on the right of the
~a peak (black star). (b) Quantification of concentrations from (a). The rates from exponential fits were
0.08 ± 0.01 and 0.14 ± 0.02 hr-1 for ~a and ~B, respectively. (c) Product concentrations, cprod., 0.5 hours
after the start of the reaction plotted against initial template concentrations. Reactions were started with
fragments preincubated in the reaction buffer for 0, 0.5, 1, and 1.5 hours. Linear fits gave ligation rates of
1.08 ± 0.04, 0.44 ± 0.04, 0.32 ± 0.02, and 0.26 ± 0.02 hr-1, respectively. The respective replication yields
were (61 ± 10)%, (28 ± 10)%, (19 ± 4)%, and (15 ± 3)% in 0.5 hours. (d) Data from (c) were replotted
to demonstrate the exponential decrease in product concentrations during the preincubation in EDC. The
exponential fits yielded the rate constants of 1.14 ± 0.12, 1.14 ± 0.24, 1.38 ± 0.36, and 1.26 ± 0.24 hr-1
for the initial template concentrations of 2.0, 1.4, 1.0, and 0.4 µM, respectively.
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3.2 Characterization of fragment modification
A closer look at the fragments incubated with EDC over time revealed that the fragments bearing 3′-
phosphate groups decreased in concentration (Figure 5a). Additionally, a shoulder next to the peak
assigned to fragment ~a started to form. Shoulder formation only occurred in the presence of the 3′-
phosphate group (Figure 6a), suggesting that it originated from the fragment ~a modified by EDC on the
3′-phosphate group (Figure 6b). Since EDC-modified fragments are less negatively charged and 155 Da
heavier than unmodified fragments, they were expected to run slower in a gel electrophoresis experiment,
confirmed by the position of the shoulder on the right of the peak. The fragment ~B had a 3′-phosphate
group and was decreasing in concentration over time as well (Figure 5a). This observation suggested
that ~B was also modified by EDC on the 3′-phosphate group. The expected shoulder in this case was
hidden by the dominant peak combined from the individual peaks of fragments b and A.
The position of each fragment was identified using a ladder (Figure 6c) and quantified (Figure 5b).
Exponential fits, assuming full final degradation of phosphorylated fragments, produced degradation
rates of 0.08 ± 0.01 hr-1 for ~a and 0.14 ± 0.02 hr-1 for ~B.
The effect of fragment modification on the ligation rate
According to our hypothesis, the 3′-phosphate group of the phosphorylated fragments was modified
by EDC. If true, such modified fragments would still be able to bind to the templates and replicates
but would not be able to participate in the ligation reaction. Therefore, a strong effect of a fragment
incubation in EDC on the ligation rate was expected.
To test this hypothesis, I first measured the ligation rate under the reaction conditions. Reactions
with varied initial template concentrations were followed for 0.5 hours and the product concentrations
were quantified (Figure 5c). Product concentration showed a linear dependence on the initial template
concentration, suggesting an underlying exponential behavior of the reaction. The ligation rate obtained
from the linear fit was 1.08 ± 0.04 hr-1. The experiment resulted in a replication yield of (61 ± 10) %
in 0.5 hours, where the replication yield is defined as the replicate concentration at time t divided by the
template concentration at time t = 0.
To test if EDC indeed formed a side product with the fragments and inhibited their ligation, I incu-
bated the fragments in EDC for 0.5, 1.0, or 1.5 hours in the absence of templates under the temperature
cycling conditions of the reaction. After the so-called preincubation time without templates, the template
strands were added to start the ligation reaction. The ligation rate decreased to 0.44 ± 0.04, 0.32 ± 0.02,
and 0.26 ± 0.02 hr-1 after 0.5, 1.0, and 1.5 hours of preincubation, respectively. Respective replication
yields were (28 ± 10)%, (19 ± 4)%, and (15 ± 3)% in 0.5 hours. In the experiment where the fragments
were first incubated for 1.5 hours with EDC, both the replication rate and yield decreased 4-fold com-
pared to no preincubation. The result suggested that EDC and fragments in the absence of templates
were forming a side product that inhibited ligation.
To quantify the decrease in the ligation rate due to the preincubation of fragments, the data were
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Figure 6: Fragment peaks on the gel electrophoresis traces, and 3′-phosphate group-dependent fragment
modification.
(a) The gel electrophoresis traces of the samples where the fragments A and ~a were mixed together
and incubated in the reaction buffer for 0, 1, or 3 hours (solid lines). Fragment ~a was used either with
(left graph) or without (right graph) a 3′-phosphate group. Over time, a shoulder on the right of the
~a fragment peak emerged only in the case when the fragment ~a had a 3′-phosphate group. Running
each strand separately (dashed lines) allowed the clear identification of the species peaks. (b) A likely
pathway for the formation of a modified fragment is shown. The EDC-activated phosphate intermediate
O-phosphorylisourea (left) could isomerize to produce N-phosphorylurea [43, 57] (right) that would not
be able to support the condensation reaction. Since fragments with 3′-phosphate groups modified in
such a way would still be able to bind to the corresponding templates, an inhibiting effect on the ligation
reaction was expected. R1=C2H6, R2=CH3–CH2–CH2–N–(CH3)2 (c) The gel electrophoresis traces
of the samples where the four fragments ~B, b, A, and ~a were mixed together and incubated in the
reaction buffer for 0 or 4 hours (solid lines). Running each strand separately (dashed lines) allowed the
clear identification of the species peaks.
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replotted with the final product concentration on the y-axis and the fragment preincubation time on the
x-axis (Figure 5d). The exponential fits with assumed zero asymptote averaged to an effective first order
rate constant of 1.23 ± 0.11 hr-1.
3.3 Kinetic description and simulations
Simulation without fragment modification
To understand the replication behavior in the reaction, I modeled the experimental system with a set of
rate equations:
BA + a + b
k12nton
−−−⇀↽−−
k12nto f f
[BA ·a] + b
k12nton
−−−⇀↽−−
k12nto f f
[BA ·a ·b] (1)
BA + a + b
k12nton
−−−⇀↽−−
k12nto f f
[BA ·b] + a
k12nton
−−−⇀↽−−
k12nto f f
[BA ·a ·b] (2)
ab + A + B
k12nton
−−−⇀↽−−
k12nto f f
[A ·ab] + B
k12nton
−−−⇀↽−−
k12nto f f
[B ·A ·ab] (3)
ab + A + B
k12nton
−−−⇀↽−−
k12nto f f
[B ·ab] + A
k12nton
−−−⇀↽−−
k12nto f f
[B ·A ·ab] (4)
[BA ·a ·b]
klig
−−→ [BA ·ab] (5)
[B ·A ·ab]
klig
−−→ [BA ·ab] (6)
[BA ·ab]
k24nton
−−−⇀↽−−
k24nto f f
BA + ab (7)
A + a
k12nton
−−−⇀↽−−
k12nto f f
[A ·a] (8)
B+ b
k12nton
−−−⇀↽−−
k12nto f f
[B ·b] (9)
Equations 1-4 describe the reversible formation of the termolecular complexes between templates and
their complementary fragments with association and dissociation rate constants k12nton and k
(12nt,T )
o f f , where
T refers to the temperature dependence of the dissociation rate. Following the formation of the complex,
an irreversible ligation reaction can occur with a ligation rate klig (equations 5-6). The resulting complex
can reversibly dissociate with association and dissociation rate constants k24nton and k
(24nt,T )
o f f (equation 7)
leading to the reshuffling of the strands such that the reaction can start again. Complementary frag-
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Figure 7: Determination of rates for the simulation.
(a) Product concentrations 0.5 hours after the start of the reaction. Templates were replaced with ~ab or
~BA (light and dark blue points) for the initial ligation, or initial ligation was started with templates as be-
fore (black points). The ligation rates from the linear fits were 1.78 ± 0.08, 1.40 ± 0.14, 1.32 ± 0.06 hr-1,
respectively. Respective replication yields were (87 ± 11)%, (67 ± 15)%, and (55 ± 6)% in 0.5 hours. (b)
Product concentrations quantified 10 min after the start of the reaction. The linear fit produced a ligation
rate of 2.16 ± 0.12 hr-1, with a replication yield of (39 ± 7)% in 10 minutes. (c) Baseline-corrected
melting curves of the complementary templates and complementary fragments in the control buffer vs in
the reaction buffer. (d) Baseline-corrected melting and annealing curves of the complementary templates
and complementary fragments in the reaction buffer used to quantify the dissociation rates.
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ments can also reversibly bind to each other with association and dissociation rate constants k12nton and
k(12nt,T )o f f (equations 8-9). I did not differentiate between ligation on templates and replicates that contained
polycytidine tails since the tags were not found to significantly affect the ligation reaction as shown in
Figure 7a.
Ligation rate klig I observed in the previous experiments that the replication rate slowed down during
the first 30 minutes of the reaction (Figure 3, inset). I assumed that the product inhibition and fragment
modification had already affected the reaction, and the ligation rate quantified from this data was being
underestimated. To obtain the value klig that was independent of the product inhibition and fragment
modification effects, product concentrations were measured 10 min after the start of the reaction for
different initial template concentrations (Figure 7b). This ligation rate, which should be least affected
by the modification reactions, averaged to klig of 2.16 ± 0.12 hr-1, about two-fold higher as compared to
measuring the product formation after 30 minutes.
Association and dissociation rates I obtained the kon value of 1440 µM-1 hr-1 for a short DNA oligonu-
cleotide composed only of adenine and thymine nucleobases from literature [62, 104]. The rates k12nton
and k24nton were assumed length independent and were both set equal to this kon value. Since I wanted
to explicitly model the temperature cycling, I needed to determine k12nt,20
◦C
o f f , k
12nt,65◦C
o f f , k
24nt,20◦C
o f f , and
k24nt,65
◦C
o f f .
The values for k12nt,20
◦C
o f f and k
24nt,20◦C
o f f were quantified experimentally by analyzing melting curves.
First, I showed that the duplexes in the reaction buffer were significantly more stable than in the con-
trol buffer (reaction buffer without EDC) (Figure 7c). Therefore, measuring the dissociation rates in
the control buffer would have yielded overestimated values. Then, I measured annealing curves in the
reaction buffer and observed a hysteresis between the melting and annealing curves for all the tested
species combinations (Figure 7d). This meant that a slower temperature ramp was required to reach the
dynamic equilibrium at each temperature point of data acquisition. However, I expected that the slower
temperature ramp would increase the extent of EDC-induced unwanted modifications of the DNA bases
in the single-stranded form [15]. Instead of slowing down the temperature ramp, the minimum and max-
imum kx nt,20
◦C
o f f values were estimated from the melting and annealing curves, respectively. I quantified
k24nt,20
◦C
o f f and k
12nt,20◦C
o f f to be within the bounds of (2 to 64100) 10
-4 hr-1 and (17 to 339) hr-1, respec-
tively. Although the range of kx nt,20
◦C
o f f values is large, these dissociation rates are slower than the melting
kinetics of the implemented thermal cycling. The reaction model was not expected to be sensitive to
variations of this parameter as indeed was the case (as shown below in Figures 8a, b).
The values k24nt,65
◦C
o f f and k
12nt,65◦C
o f f estimated in the same way yielded respective bounds of
(0.4 to 9.6) 106 hr-1 and (0.4 to 1.1) 108 hr-1. The result of the large dissociation rates is the absence
of duplex strands at equilibrium at 65°C. Without significantly altering the simulation results, I approx-
imated the rates k24nt,65
◦C
o f f and k
12nt,65◦C
o f f to be 100 times higher than the chosen kon value. This allowed
the dissociation of the majority of the DNA complexes during the simulated melting steps and reduced
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Table 2: Two sets of rate constants that model temperature cycling in the system without and with
modification (normal and bold terms).
Rate Constant 20°C for 30 min 65°C for 16 sec
Dissociation for 12nt long strands k12nt,20
◦C
o f f k
12nt,65◦C
o f f
Dissociation for 24nt long strands k24nt,20
◦C
o f f k
24nt,65◦C
o f f
Association for all strands kon kon
Ligation klig klig
Feeding 0 k f eed
Dilution 0 kdil
Modification kmod kmod
the computational load for the simulation.
EDC hydrolysis, fragment feeding and dilution The rate of EDC hydrolysis at the pH value 6.5 of
the reaction was quantified from literature to be 0.047 hr-1 [80, 89, 97, 100], leading to 75% of the initial
EDC concentration left after 6 hours of the reaction, maintaining the >2500-fold excess of EDC over the
DNA oligonucleotides. Therefore, I did not explicitly model the hydrolysis of EDC in the simulation.
Lastly, feeding and dilution were modeled to occur during the warm stage of the reaction. For this,
the rates k f eed and kdil were fixed to 0 for the reaction at 20°C and to 0.625 sec-1 and 0.00625 sec-1,
respectively, for the reaction at 65°C. The values were chosen in order to model the experimental feeding
and dilution concentrations.
Simulation details To simulate the reaction curves, 15 ODEs based on equations 1-9 (terms not in bold
in the Table 3) were solved in MATLAB. To simulate temperature cycling, the ODEs were alternately
solved with two sets of rate constants (Table 2). The ODEs were solved using an ode15s solver to obtain
concentrations of all the reaction species at time points chosen by the solver. The absolute and relative
tolerances of the solver were set to 10-4 and 10-2, respectively.
The simulation performed for upper and lower bounds of k12nt,20
◦C
o f f and k
24nt,20◦C
o f f values both pro-
duced curves that showed rapid exponential amplification behavior far from our experimental results
(Figure 8a). Noteworthy, the simulation matched the experimental data of the first 0.5 hours, where the
inhibition from the fragment modification was probably still weak.
Simulation with fragment modification
To test the hypothesis that the observed formation of the EDC-induced fragments could significantly
affect the behavior of the system, I added a fragment modification pathway to the system of equations:
30
3 RESULTS 3.3 Kinetic description and simulations
Figure 8: Simulation of the ligation reaction and fit of the experimental data.
(a) Cross-replication was modeled with a system of ODEs used to simulate the concentration of repli-
cates. Without a modification pathway, the experimental rates predicted an exponential amplification of
the templates that did not match the data. (b) By including a modification pathway, the deviations could
be explained quantitatively.
B
kmod
−−−→ Bmod (10)
a
kmod
−−−→ amod (11)
[B ·ab]
kmod
−−−→ [Bmod ·ab] (12)
[BA ·a]
kmod
−−−→ [BA ·amod] (13)
[B ·A ·ab]
kmod
−−−→ [Bmod ·A ·ab] (14)
[BA ·a ·b]
kmod
−−−→ [BA ·amod ·b] (15)
[B ·bmod]
kmod
−−−→ [Bmod ·b] (16)
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[A ·a]
kmod
−−−→ [A ·amod] (17)
BA + amod + b
k12nton
−−−⇀↽−−
k12nto f f
[BA ·amod] + b
k12nton
−−−⇀↽−−
k12nto f f
[BA ·amod ·b] (18)
BA + amod + b
k12nton
−−−⇀↽−−
k12nto f f
[BA ·b] + amod
k12nton
−−−⇀↽−−
k12nto f f
[BA ·amod ·b] (19)
ab + A + Bmod
k12nton
−−−⇀↽−−
k12nto f f
[A ·ab] + Bmod
k12nton
−−−⇀↽−−
k12nto f f
[Bmod ·A ·ab] (20)
ab + A + Bmod
k12nton
−−−⇀↽−−
k12nto f f
[Bmod ·ab] + A
k12nton
−−−⇀↽−−
k12nto f f
[Bmod ·A ·ab] (21)
A + amod
k12nton
−−−⇀↽−−
k12nto f f
[A ·amod] (22)
Bmod + b
k12nton
−−−⇀↽−−
k12nto f f
[Bmod ·b] (23)
Based on the experimental observation (Figure 5a, b), the fragments ‘B’ and ‘a’ were allowed to be
modified with a modification rate kmod independent of the fragments being in a free or a bound state
(equations 10-17). The modification allowed the fragments to bind to the complementary fragments, the
templates, and the replicates (equations 18-23) but inhibited the ligation reaction, sequestering templates
and replicates from the reaction (equations 18-21).
Table 3: ODEs describing the experimental system without and with modification (normal and bold
terms).
Left side Right side of the equation
dB/dt −kdil ∗B+ k f eed−kmod ∗B + k12nto f f ∗ ([B ·b] + [B ·ab] + [B ·A ·ab])−
k12nton ∗ (B∗b + B∗ab + B∗ [A ·ab])
dA/dt −kdil ∗A + k f eed + k12nto f f ∗ ([A ·a] + [A ·ab] + [B ·A ·
ab]+[A ·amod] + [Bmod ·A ·ab])−
k12nton ∗ (A∗a + A∗ab + A∗ [B ·ab]+A∗amod + A∗ [Bmod ·ab])
db/dt −kdil ∗b + k f eed + k12nto f f ∗ ([B ·b] + [BA ·b] + [BA ·a ·
b]+[Bmod ·b] + [BA ·amod ·b])−
k12nton ∗ (b∗B+ b∗BA + b∗ [BA ·a]+b∗Bmod + b∗ [BA ·amod])
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da/dt −kdil ∗a + k f eed−kmod ∗a + k12nto f f ∗ ([A ·a] + [BA ·a] + [BA ·a ·b])−
k12nton ∗ (a∗A + a∗BA + a∗ [BA ·b])
dBA/dt −kdil ∗BA + k12nto f f ∗ ([BA ·a] + [BA ·b] + [BA ·amod])−
k12nton ∗ (BA∗a + BA∗b + BA∗amod) + k24nto f f ∗ [BA ·ab]− k
24nt
on ∗BA∗ab
ab/dt −kdil ∗ab + k12nto f f ∗ ([A ·ab] + [B ·ab] + [Bmod ·ab])−
k12nton ∗ (ab∗B+ ab∗A + ab∗Bmod) + k24nto f f ∗ [BA ·ab]− k
24nt
on ∗ab∗BA
d[BA ·ab]/dt −kdil ∗ [BA ·ab]+k24nton ∗ab∗BA−k
24nt
o f f ∗ [BA ·ab]+klig ∗ ([B ·A ·ab]+ [BA ·a ·b])
d[BA ·b]/dt −kdil ∗ [BA ·b] + k12nto f f ∗ ([BA ·a ·b] + [BA ·amod ·b]− [BA ·b])+
k12nton ∗ (BA∗b− [BA ·b]∗a− [BA ·b]∗amod)
d[BA ·a]/dt −kdil ∗ [BA ·a]−kmod ∗ [BA ·a] + k12nto f f ∗ ([BA ·a ·b]− [BA ·a])+
k12nton ∗ (BA∗a− [BA ·a]∗b)
d[B ·ab]/dt −kdil ∗ [B ·ab]−kmod ∗ [B ·ab] + k12nto f f ∗ ([B ·A ·ab]− [B ·ab])+
k12nton ∗ (B∗ab− [B ·ab]∗A)
d[A ·ab]/dt −kdil ∗ [A ·ab] + k12nto f f ∗ ([B ·A ·ab] + [Bmod ·A ·ab]− [A ·ab])+
k12nton ∗ (A∗ab− [A ·ab]∗B− [A ·ab]∗Bmod)
d[B ·A ·ab]/dt −kdil ∗ [B ·A ·ab]−kmod ∗ [B ·A ·ab] + k12nton ∗ (B∗ [A ·ab] + A∗ [B ·ab])−
2k12nto f f ∗ [B ·A ·ab]− klig ∗ [B ·A ·ab]
d[BA ·a ·b]/dt −kdil ∗ [BA ·a ·b]−kmod ∗ [BA ·a ·b] + k12nton ∗ (b∗ [BA ·a] + a∗ [BA ·b])−
2k12nto f f ∗ [BA ·a ·b]− klig ∗ [BA ·a ·b]
d[B ·b]/dt −kdil ∗ [B ·b]−kmod ∗ [B ·b] + k12nton ∗B∗b− k12nto f f ∗ [B ·b]
d[A ·a]/dt −kdil ∗ [A ·a]−kmod ∗ [A ·a] + k12nton ∗A∗a− k12nto f f ∗ [A ·a]
dBmod/dt −kdil ∗Bmod + kmod ∗B + k12ntoff ∗ ([Bmod ·b] + [Bmod ·ab] + [Bmod ·A ·ab])−
k12nton ∗ (Bmod ∗b + Bmod ∗ab + Bmod ∗ [A ·ab])
damod/dt −kdil ∗amod + kmod ∗a + k12ntoff ∗ ([A ·amod] + [BA ·amod] + [BA ·amod ·b])−
k12nton ∗ (amod ∗A + amod ∗BA + amod ∗ [BA ·b])
d[Bmod ·ab]/dt −kdil ∗ [Bmod ·ab] + kmod ∗ [B ·ab] + k12ntoff ∗ ([Bmod ·A ·ab]− [Bmod ·ab])+
k12nton ∗ (Bmod ∗ab− [Bmod ·ab]∗A)
d[BA ·amod]/dt −kdil ∗ [BA ·amod] + kmod ∗ [BA ·a] + k12ntoff ∗ ([BA ·amod ·b]− [BA ·amod])+
k12nton ∗ (BA∗amod− [BA ·amod]∗b)
d[Bmod ·A ·ab]/dt −kdil ∗ [Bmod ·A ·ab] + kmod ∗ [B ·A ·ab]+
k12nton ∗ (Bmod ∗ [A ·ab] + A∗ [Bmod ·ab])−2k12ntoff ∗ [Bmod ·A ·ab]
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d[BA ·amod ·b]/dt −kdil ∗ [BA ·amod ·b] + kmod ∗ [BA ·a ·b]+
k12nton ∗ (b∗ [BA ·amod] + amod ∗ [BA ·b])−2k12ntoff ∗ [BA ·amod ·b]
d[Bmod ·b]/dt −kdil ∗ [Bmod ·b]+kmod ∗ [B ·b] + k12nton ∗Bmod ∗b−k12ntoff ∗ [Bmod ·b]
d[A ·amod]/dt −kdil ∗ [A ·amod]+kmod ∗ [A ·a] + k12nton ∗A∗amod−k12ntoff ∗ [A ·amod]
I approximated the modification rate by using the average rate of the decrease of the ligation rate due
to the fragment preincubation in EDC (1.23 ± 0.11 hr-1) that was quantified above (Figure 5d). Since the
new rate equations were introduced, 23 new ODEs were constructed (terms in bold in the Table 3). Since
the solution of the kinetic model with fragment modification reproduced the experimental behavior of the
system sufficiently well, I then used this kinetic model to fit the experimental data for the modification
rate. The fit was realized with the lsqcurvefit tool of MATLAB with kmod as the only fit parameter. For
upper and lower bounds of k12nt,20
◦C
o f f and k
24nt,20◦C
o f f values, the fit produced the kmod values of 2.69 hr
-1
and 2.63 hr-1, respectively. This was in good agreement with the experimental data (Figure 8b).
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4 Discussion and Outlook
In this project, I established a DNA-based system that allows to run nonenzymatic exponential DNA
replication-by-ligation experiments using EDC as a condensing agent for the first time over several cycles
of ligation and melting to overcome product inhibition. Additionally, a selection pressure was mimicked
by diluting the reaction. The cross-replicating DNA strands amplified 2.2-fold in 6 hours in a sustained
fashion under the feeding conditions despite their serial dilution. This result indicates that DNA strands
with the defined complementary sequences can survive under simple in situ activation conditions for
well-chosen experimental parameters.
The problem of fragment modification
Faster amplification in the presented system was suppressed by the EDC-induced fragment modification,
as was shown by detailed modeling of the experimental system with rate equations and simulation of the
experimental data with ODE solutions. There are several possible mechanisms for the fragment modi-
fication. Activated oligonucleotides with a length as short as 4 nucleobases can effectively cyclize pre-
venting them from base-pairing and consequently templated ligation reactions [32, 41]. Another source
of fragment modification could have been the isomerization of the EDC-activated phosphate group in-
termediate, leading to the formation of a stable, non-reactive group, analogous to a known isomerization
reaction of O-acylisourea to N-acylurea (Figure 6b). Fragments with non-reactive phosphate groups
would still be able to base pair with templates but would not be able to support ligation reactions and,
thus, would inhibit the replication by sequestering template strands.
Experimental and theoretical modification rates
Accounting for fragment modification in the kinetic model allowed to closely simulate the experimental
behavior of the system with all the rate constants except the modification rate derived from the exper-
iments. Importantly, I could obtain the modification rate kmod from fitting the experimental data with
the solution of the ODE system. The fitted value kS immod = 2.66 hr
-1 matched the experimentally estimated
value kExpmod = 1.23 hr
-1 within a factor of 2. The discrepancy likely originated from the temperature de-
pendence of the modification rate or from the effects of the EDC hydrolysis product, its urea, on the
DNA duplex stability. Both effects could not be explicitly modeled.
Effect of modulating reaction parameters
The kinetic model is central to finding reaction conditions that can support sustained replication. It
predicts that the replication system is very sensitive to the modulation of the modification and ligation
rates. Reduction in the modification rate by a factor of 1.5 should significantly speed up the replication
(Figure 9a, orange solid line) with an amplification factor of four within 5 hours. Reduction by a factor
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Figure 9: Simulation of the effect of the reaction rates modulation on the ligation reaction outcome.
(a) The result of the modulation of rates kmod and klig on the replication reaction. (d) The result of the
modulation of dilution and feeding rates. (c) Additional curves to the modulation of rates kmod and klig
on the replication reaction: a factor two smaller kmod or larger klig lead to a dramatically more effective
replication system. (d) The result of the modulation of the temperature of the cold stage of the reaction
on replication. (e) The result of the modulation of the initial fragment concentration on replication.
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of two should result in a drastic increase in replication with an amplification factor of roughly fifteen
within 5 hours (Figure 9c, orange solid line).
An increase in the ligation rate had a less significant effect on the amplification factor, i.e. the
amplification factor reached four and six within 5 hours when the ligation rate was increased by factors
of 1.5 and 2, respectively (Figure 9a and c, orange dashed line). Therefore, focus should be placed on
finding ways to reduce the modification rate by, for example, finding a condensing agent with less side
product formation, e.g. diamidophosphate [23], or a mechanism for a turnover of modified fragments.
The effects of ligation and modification rates are, however, in direct competition. Thus, an improved
activation protocol would need to maintain a high ligation rate. An increase in the modification rate and
decrease in the ligation rate could easily result in a system with a negative fitness (Figure 9a).
Finding a balance between dilution and feeding is of equal importance. Higher dilution rate and less
fragment feeding should result in a negative fitness of the system (Figure 9b). It could be of interest to
decrease the dilution rate or increase feeding to drive stronger amplification. However, a too low dilution
rate would lift the environmental pressure that is desired for fast evolution experiments, and too high
feeding would result in insoluble fragment concentrations.
The effect of the modulation of other parameters was also estimated with the model, such as tem-
perature of the cold reaction stage and the initial concentration of the fragments in the system. Lower
temperature during the stage of the reaction when ligation occurs does not significantly affect the repli-
cation, while 5°C and 10 °C higher temperatures are predicted to significantly suppress the replication
(Figure 9d). The effects of the temperature modulation originate from the higher dissociation rates of
the duplexes at higher temperatures. The modification and ligation rates were assumed to be temperature
independent in this analysis.
For the analysis of the effect of the initial fragment concentration on the replication reaction, the
model allowed to conclude that the amount of fragment strands in the initial mix should be balanced
between providing excess over template strands but not saturating the system with too many fragments
(Figure 9e). Too many fragments would inhibit replication by sequestering template strands when mod-
ified.
Towards Darwinian-like evolution experiments starting from random sequence pools
The presented DNA cross-replicator works on a defined set of DNA strands. However, it is expected that
any two strands brought together by a template in the presence of EDC and 3′-phosphate groups would
ligate, producing longer molecules that can serve as templates in other reactions. The efficiency of
templated ligation between random strands would likely depend on the geometry and, thus, the sequence
composition of the ligation site [41]. Such sequence dependence in a pool of strands replicating by
ligation could represent one way of how specific sequences were selected from random pools of short
oligonucleotides likely present on the prebiotic Earth.
Replication-by-ligation of short strands could lead to Darwinian-like evolution experiments where
longer strands with useful functions could be produced and selected from random pools of short oligonu-
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cleotides. Strands in mixtures of short random oligonucleotides supplied with 3′-phosphate groups would
serve at the same time as templates and fragments for ligation, creating a cascade of reactions. Cycles
of ligation/melting in such systems could lead to effective strand elongation. Longer strands could then
adopt secondary structures allowing them to perform useful functions. Since the replication in such
a network could be achieved by chemical means by the demonstrated ligation chain reaction, the first
oligonucleotide enzymes would not need to necessarily execute a replication function.
Evolution experiments from random sequence pools would require managing limited but large se-
quence spaces already at the sequence length of 12 bases. There are 212 = 4096 12-nt long sequences
composed of two types of bases. That implies that the feeding concentration for a replication reaction that
started from random 12-nt long strands would be 4096*x µM, where x µM is the feeding concentration
per strand. Thus, starting evolution experiments from shorter strands is of practical interest. Preliminary
experiments show, however, that ligating the 6nt-long fragments on the 12nt-long templates does not
result in sufficiently high yields at lower temperatures required for hybridization of shorter strands.
Short summary
In summary, in this project I realized a cross-replicating system composed of DNA oligonucleotides
that are in situ activated with the carbodiimide-based condensing agent EDC that shares its reactive
group with the tautomer of the prebiotically plausible cyanamide. The system achieved a positive fitness
over several cycles of ligation/melting with a supply of fresh fragments every second cycle. I devel-
oped a detailed kinetic model in order to explain the experimental data. This model provided important
insights into finding conditions for sustained replication. As an outlook, the realized reaction system
serves as a stepping stone towards studying evolution of reaction systems composed of short random
oligonucleotides. The goal will be to experimentally show how nonrandom reaction networks of longer
oligonucleotides helping each other in preserving their sequence information might have originated.
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Biological molecules in the context of living organisms interact inside complex environments, such as
cell cytoplasms, extracellular matrices, and blood plasma. How strong two molecules interact with each
other depends on the concentration of the interacting species, and on how likely the two molecules are
to form a noncovalent bond with each other. The likelihood of a molecular interaction in solution, also
called an affinity of interaction, is described quantitatively by an equilibrium dissociation constant KD . A
KD value between the two interacting species A and B is given by
[AB]
[A][B] , where [AB] is the concentration
of a molecular complex AB in equilibrium, [A] is the concentration of free species A in equilibrium, and
[B] is the concentration of free species B in equilibrium.
The dissociation constant is commonly considered to be determined by the stereochemical proper-
ties of the interacting molecules. The properties of the environment, where interaction takes place, are
often undermined. However, the various components of the complex environment inside living organ-
isms could play a crucial role in determining the strength of the interaction between the molecules. In
blood plasma a lot of parameters could affect the binding between the molecules of interest, such as the
pH value, the salt conditions, the presence of additional small molecules, lipids, or proteins. These pa-
rameters could change the chemical properties of the molecules, such as their charge or hydration shell,
hinder the interaction via competitive binding to the same binding site, or by changing the binding site
via interacting with an allosteric binding pocket.
If this hypothesis is true, the ability to measure not only the concentration of the molecule of interest
but also its affinity to the target in the same environment is of significant importance.
To test this hypothesis, I developed an assay sensitive to both the concentration of the interacting
partners and the affinity of their interaction. Specifically, I focused on the interaction between the two
proteins associated with a disease condition in the context of human blood plasma environment: the
formation of the noncovalent encounter complex between the enzyme neutrophil elastase (NE) and its
inhibitor α-1-antitrypsin (AAT).
α-1-antitrypsin deficiency disorder
The interaction between NE and AAT has been well studied in vitro using the two purified proteins
in standard buffers [14]. AAT inhibits NE irreversibly in a two-step reaction [65]. The first and rate-
determining step is the formation of a reversible encounter complex between NE and AAT, where AAT
mimics NE’s substrate [22, 40].
In a human body physiology, NE is known as an important regulator of the inflammatory pro-
cesses. NE modulates the biological activity of cytokines and chemokines and activates receptors on
neutrophils [64]. It is highly important that the body controls duration of the NE activity and, thus, the
pro-inflammatory effect of NE, for example by AAT inhibition. Exactly how important the tight control
over NE activity is, could be seen from a variety of diseases associated with low levels of AAT in blood
plasma.
40
5 MOTIVATION AND INTRODUCTION
Low plasma levels of AAT predispose to a variety of diseases, most commonly recognized in patients
suffering from lung emphysema and chronic obstructive pulmonary disease [25, 84]. The reason for
decreased AAT levels is often genetical. A relatively common Z-mutation (Glu342Lys) in the AAT
gene sequence [34] accounts for 95% of patients with clinically relevant manifestations. AAT with the
Z-mutation is also called the Z-variant AAT.
Although all the homozygous carriers of the Z-variant AAT (ZZ-carriers) have reduced AAT levels,
not everyone of them develops lung emphysema or other clinically relevant symptoms [25, 83, 84]. The
reason for this is unclear and clinical tests predicting, who of the ZZ-carriers will develop symptoms do
not exist.
During diagnostic tests in clinics, AAT concentration in plasma of ZZ-carries is determined. The
standard methods are used, such as nephelometry or commercial ELISA. These assays, however, do not
assess the functionality and inhibitory properties of the patient’s AAT in the natural milieu of human
plasma. Oligomers, inactive, cleaved, or oxidized forms of AAT, all contribute to the measurements,
and the fraction of actually functional proteins remains unclear. Moreover, these approaches focus only
on the concentration of AAT [25, 34, 83, 96], although kinetically efficient formation of the encounter
complex also depends on the dissociation constant between NE and AAT [22, 40].
The problem of affinity determination in blood plasma
Functional assessment of the dissociation constant in native environments has been a major challenge to
date [81, 85]. Immunoassays and surface plasmon resonance are the current standard approaches to quan-
tify concentrations in plasma and determine affinities of known targets [54, 55]. However, both methods
require surface immobilization of an antigen or an antibody, potentially imposing steric hindrance and
molecular activity problems. Immobilization-free approaches based on fluorescence resonance energy
transfer (FRET) require availability and labeling of both interacting partners [45, 92]. Therefore, FRET-
based methods cannot be used directly in the plasma sample to determine the affinity of a person-specific
endogenous protein to its target.
Microscale thermophoresis
Microscale thermophoresis (MST) is a recently established immobilization-free affinity measurement
technique that has been applied to characterize ligand-binder interactions and affinity constants ranging
from pM to mM under challenging conditions [37, 78, 96]. MST employs the physical phenomenon
of thermophoresis – the movement of molecules in a temperature gradient. Biomolecules tend to move
against the temperature gradient causing the depletion of a biomolecule in the heated spot. In MST
experiment, the depletion of the fluorescently labeled molecule, called the binder, changes upon binding
to another molecule, called the ligand. Measuring the depletion at increasing ligand concentrations
results in a binding curve, which can be used to derive the dissociation constant.
In a previous work using an MST-based approach, it was shown how the affinity, as well as the
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concentration of the ligand, can potentially be determined in complex matrices such as blood serum [49].
However, due to the limitations in the sensitivity of the assay, only an additionally spiked but not initially
present ligand could have been detected in serum. Also, low affinity interactions remained a challenge,
because for high KD values, the approach requires very high and often unrealizable concentrations of the
unlabeled binder in order to establish a complete binding curve.
Project goal
In this work, my goal was to develop an MST-based assay for measurements directly in blood plasma
that would overcome the limitations of the previous approach. To test the assay, I aimed to apply it to
study the formation of the NE-AAT encounter complex in blood plasma sample.
This project was conducted in a collaboration with Therese Dau from the laboratory of Dieter Jenne,
both associated with Comprehensive Pneumology Center, Institute of Lung Biology and Disease (iLBD),
University Hospital, Ludwig Maximilians University, and Helmholtz Zentrum München. My contribu-
tion to the project was in the assay development, its theoretical description, and evaluation of all the MST
experimental data. All the MST experiments were conducted by both of us.
Since my contribution was based on the implementation of the MST technology, I will now give
a more detailed introduction to a typical MST experiment and a literature overview of the currently
established bioanalytical applications of MST.
5.1 A typical MST experiment
The biophysics-based technology of MST was first developed in 2010 [3] and stemmed from the research
on why molecules undergo thermophoresis in solutions [16, 17]. Thermophoresis, or thermodiffusion,
is a directed movement of molecules in a temperature gradient. The effect has first been described
experimentally by Carl Ludwig in 1856 [51]. While thermophoresis in gases is a theoretically understood
phenomenon, thermophoresis in liquids remains an active area of research. There are two common
approaches to describing thermophoresis in liquids. One assumes that it is a local non-equilibrium effect
and uses force fields, particle-particle potentials, and fluid dynamics among others to describe it [4,
59, 63, 76]. Another approach assumes a local thermodynamic equilibrium for moderate temperature
gradients and describes thermophoresis applying equilibrium thermodynamics [10, 16].
In a typical thermophoresis experiment, the concentration of the molecule is depleted at higher tem-
peratures. For a phenomenological description, a linear drift response is used [9]. The velocity of a
molecule in a temperature gradient, v, depends linearly on the temperature gradient, ∇T , with a propor-
tionality constant DT :
v = −DT∇T
DT is called thermal diffusion coefficient or thermophoretic mobility. The thermal drift results in a
concentration gradient, ∇c, leading to mass diffusion with a diffusion coefficient D. The flow density
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considering the thermal drift and mass diffusion for a molecule of a concentration c is given by:
j = −cDT∇T −D∇c
In steady state, the thermal drift and mass diffusion balance each other out, such that j = 0. This
leads to:
∇c
c
= −S T∇T (24)
where S T = DT/D is a Soret coefficient of a molecule. Integrating equation 24 for small temperature
differences dT and small concentration changes dc leads to:
c
c0
= e−S T dT (25)
where c0 is an initial concentration and c is a steady state concentration after temperature is changed
by dT . Though theory continues to develop, the predominant parameters that affect the S T of a molecule
under physiological conditions were found to be the charge of the molecule, its size, and its interaction
with the solvent [17]. Since at least one of the mentioned parameters is very likely to be affected when
one molecule binds to another, the change in thermophoretic behavior upon binding is used as a readout
to monitor and quantify binding interactions. The method was named microscale thermophoresis to
highlight that the movement of molecules occurs within microscale temperature gradients.
In a typical MST experiment, a solution of a fluorescently labeled molecules is filled into a trans-
parent glass capillary and placed under a fluorescence microscope (Figure 10a). A temperature gradient
is created by an infrared (IR) laser that is coupled into the optical path of the fluorescence microscope.
A small temperature increase of 4-12 K is obtained (Figure 10b). Most of the biologically relevant
molecules have a positive S T and undergo "positive" thermophoresis. This means that they move to-
wards the colder area of the temperature gradient, resulting in a depletion of the fluorescence signal in
the observed heated spot (Figure 10c). Depletion is calculated as the difference between the steady state
fluorescence signal with the IR laser on and with the laser off. Since thermophoresis of free and bound
states of a fluorescent molecule is different, the depletion value over the range of ligand concentrations
varies (Figure 10c) and can be replotted against the ligand concentration to obtain a typical binding curve
(Figure 10d, circles).
For two molecules A and B binding to each other with the dissociation constant KD, one can write:
KD =
[A][B]
[AB]
(26)
[A]total = [A] + [AB] (27)
[B]total = [B] + [AB] (28)
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Figure 10: A typical MST experiment.
(a) Adopted from [49]. Sample with a fluorescent molecule is filled into a glass capillary. Illumination
from the light-emitting diode (LED) is focused on the sample. The infrared (IR) laser for heating is
coupled into the optical path of the microscope via the dichroic mirror and is focused on the sample
with the standard objective. The detection is achieved with the charge-coupled device (CCD) camera.
(b) Adopted from [49]. The established temperature profile calculated using finite element simulations
and measurements with temperature sensitive dyes. (c) Typical time traces obtained in MST experiments.
When the IR laser is switched on, the fluorescence in the observed spot is depleted due to the fast kinetics
of the temperature dependence of the dye and the slow kinetics of thermophoresis. The steady state is
achieved when thermophoresis and back-diffusion balance each other. Switching the IR laser off leads
to the back diffusion of the molecules. The steady state depletion value depends on the state of the
fluorescent molecule. Here, the bound molecule shows a smaller depletion value than a free molecule.
(d) When (1−depletion) value is plotted against the concentrations of the titrated molecule, the binding
curve is obtained (circles). It can be fitted with the solution of the two-body binding system between the
fluorescent and the titrated molecules with a KD value as the only fit parameter.
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where [A], [B], and [AB] are the equilibrium concentrations of molecules A, B, and the complex
between A and B; [A]total and [B]total are total concentrations of molecules A and B (which includes
both free and bound forms). Since total rather than equilibrium concentrations of molecules are typically
known in the experiment, substituting [A] and [B] in equation 26 with [A]total and [B]total from equations
27 and 28 and solving the resulting equation for [AB]/[A]total results in:
[AB]
[A]total
=
[A]total + [B]total + KD−
√
([A]total + [B]total + KD)2−4[A]total[B]total
2[A]total
(29)
[AB]/[A]total refers to a proportion of a molecule A that is found in a bound form in equilibrium. If
molecule A is a labeled molecule in the experiment, [AB]/[A]total can be shown to be proportional to the
fluorescence depletion at a given concentration of molecule B [49]. Equation 29 can thus be used to fit
the binding curve with a KD value as the only fit parameter (Figure 10d, dashed line).
5.2 Technical extensions of a typical MST experiment
The logical extension of the technique to a label free approach followed in 2012 with the incorporation
of an ultraviolet (UV) lamp for visualization of molecules [79]. Proteins containing tryptophan residues
can be monitored as long as neither the binding partner nor the buffer exhibits intrinsic fluorescence in
the UV range.
Over the last years, the dynamic range of the technique in terms of the lowest KD value that can be
reliably resolved has significantly improved. KD resolution is limited by the sensitivity of the detection
of a fluorescent molecule of interest. A commercial device introduced in 2014 allowed to increase the
sensitivity of fluorescence detection down to 10 pM concentration, resolving affinities as low as 1 pM
[37].
Two different approaches to upgrade the technique to a high-throughput platform were successfully
applied. A commercially available platform allows automatic pipetting of titration series and filling
solutions into capillaries. The capillaries are positioned on the chips that can then be easily placed inside
an automated MST machine for standard measurements [48].
In another high-throughput approach, the MST measurements are performed in the wells of 384-well
microplates [27]. Nanoliter sample volumes are automatically dispersed onto the bottom of cone-shaped
wells. Mineral oil is used to prevent evaporation of the samples. Measurements are then performed on
a microscope setup, where the microplate is being automatically repositioned to obtain measurements in
all the sample wells. Up to 24 sixteen-point binding curves can be measured per experiment.
Based on the variable formats of the available devices, a number of assays were proposed and suc-
cessfully implemented over the last years and will now be discussed.
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5.3 Literature overview of the bioanalytical applications of MST
Binding interactions between the purified molecules
The classical application of the MST method is to measure dissociation constants of interactions between
two molecules available in a purified form. Typically, one of the molecules is fluorescently labeled and
another is titrated against the first one to cover a concentration range of ~100 fold above and below the
expected KD value. The fluorescent label is commonly attached to the molecule, for which the labeling
procedure is the easiest. The experimenter does not have to label the smaller of the two molecules,
threatening to distort the binding, because as compared to FCS, the MST technique does not rely solely
on the change in size of the fluorescent molecule upon binding. Where possible, also a label-free MST
assay could be exploited for quantifying the bimolecular binding between two purified species.
Protein-protein binding The possibility to quantify protein-to-protein interactions with an MST ap-
proach was established already in the first papers on the technique. For example, the dissociation constant
of 10 nM was obtained for the binding between a human interferon and its specific antibody in a direct
titration experiment [96].
An interaction of an even higher affinity with the dissociation constant of 620 pM was quantified for
the therapeutic molecule Anakinra binding to its receptor, the interleukin-1. Therapeutic molecules tend
to have affinities in the pM range. The ability to quantify dissociation constants of such interactions is of
high importance when it comes to screening for modifications enhancing molecular stability and affinity.
The MST method can be applied to study bimolecular interactions in presence of other components
of the binding system. For example, MST was successfully employed to study the influence of cofactors
ATP/Mg2+ on the binding between protein kinase A (PKA) and its physiological inhibitor [38]. The
dissociation constant dropped more than 200-fold in the absence of the cofactors. Only one component
of the reaction, the inhibitor, had to be labeled for this study.
Sometimes, high concentrations of the titrated protein are not available due to protein’s poor solubil-
ity, tendency to aggregate, or limited availability. A tendency to aggregate is not always easily discernible
by eye. In the MST approach, such cases can be caught from the aberrations in the MST time trace sig-
nals (bumps in normally smooth curves) or in sudden drops of the fluorescence depletion values at high
concentrations when no secondary binding between the molecules is expected [73].
Protein-peptide binding An important advantage of using the MST technique for quantification of
protein-peptide interactions lies in the possibility to place a label on a protein. The protein in case of
protein-peptide interaction is the bigger of the two interacting partners. Labeling the protein minimizes
the possibility of the label to interfere with the binding, which may occur when the label is placed on the
peptide. FCS and fluorescence anisotropy techniques would, on the contrary, require labeling the smaller
peptide to observe a stronger change in the translational or rotational diffusion upon binding.
In the method paper of 2013, for example, the binding between the malaria related protein AMA1
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and RON2 peptide was quantified by MST [78]. The assay was performed in two different designs for
comparison: with labeling the RON2 peptide and with labeling the AMA1 protein. The expected high
affinity binding site could be quantified in both designs. However, only in the design with labeling the
AMA1 protein, the second binding site of lower affinity could be observed, highlighting the importance
of performing the assay in both configurations.
Binding between nucleic acids and proteins The quantification of binding interactions between nu-
cleic acids and proteins was shown for a 50-bp long dsDNA oligonucleotide and a Ku70/80 protein
complex [38]. Here, the MST technology was able to distinguish between the low- and high-affinity
modes of binding and produced a complex biphasic signal that could be fitted independently with two
binding curves.
A binding affinity with the dissociation constant of as low as 1 pM was successfully quantified by the
MST technique for the interaction between the Escherichia coli single-strand binding (EcoSSB) protein
and a ssDNA oligonucleotide of 70-nt in length [37]. Not just the affinity of the interaction was accessible
but also the stoichiometry of the interaction was established in this study. Two 35-nt long ssDNA strands
were binding per one EcoSSB protein molecule.
Binding to small molecules The affinities of interactions between the ATP aptamer and small molecules
ATP and AMP were quantified in a proof-of-principle experiment in the first paper on MST [3]. This
work was expanded by mapping the binding site of the ATP aptamer on the ATP molecule to a specific
region of the adenine residue [18]. This study was done by scanning binding affinities of the aptamer to
a range of ligands that were only slightly different from each other. Compared to the assays that required
radiolabeling of either the AMP or the ATP aptamer for KD determination [33, 39], the MST assay with a
fluorescently labeled aptamer is simple and allows such ligand screenings to be performed within hours.
Compared to highly charged nucleic acids that have a strong thermophoretic response, it is a more
challenging task to use thermophoresis to monitor binding between small molecules and proteins. As a
proof of principle, the binding between the calmodulin protein and Ca2+ ions was successfully quantified
[96]. Specificity of detection was proven by no observable binding to Mg2+ ions.
A binding of an ion to a protein induces a change in charge. To show that protein interactions with
uncharged small molecules could also be quantified, a binding between an uncharged inhibitor quercetin
and a PKA protein was successfully analyzed in the same paper.
Label-free MST approach is well suited for quantifying binding interactions between proteins and
small molecules. If a protein contains more than two tryptophan residues, concentrations down to 100 nM
could be detected. If a protein of interest lacks tryptophan residues, they could be introduced by mutation.
To show feasibility of such an approach, the binding interactions between a mitogen-activated protein
kinase p38α containing five tryptophan residues and three inhibitors were quantified [79]. Specificity of
the detected interactions was controlled by no observable binding of the inhibitors to the denatured p38α.
In another study, inhibition of human neutrophil elastase (HNE) by their natural inhibitors penta-
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cyclic triterpenes was studied. The study provides an example of how undesired protein aggregation can
easily be controlled for during the MST experiments [86]. Pentacyclic triterpenes have a limited solubil-
ity in an aqueous medium. Thus, DMSO or ethanol had to be used with the disadvantage of conferring
the possibility of a reduced HNE stability. When the labeled protein aggregated, the time traces recorded
in an MST experiment showed characteristic bumps. By controlling the smoothness of the time traces,
the authors observed HNE aggregation already in the presence of 5% DMSO but not in the presence of
up to 20% of ethanol in the medium. For further quantifications of the dissociation constants, ethanol
was used as a solvent of choice for the inhibitors.
Purification-free assays
Purification-free assays for protein-protein interaction studies can be divided into assays that utilize cell-
free protein synthesis and assays that use cellular expression of proteins.
MST measurements on cell-free synthesized proteins were used to establish a hierarchy of the KD
values of the interactions between the human T-cell phosphoprotein ADAP and its potential ligands,
various SH2 proteins, which were identified in a preceding pull-down assay [52]. ADAP and SH2
proteins were synthesized using commercially available cell-free systems. ADAP protein was SNAP-
tagged, allowing a directed co-translational fluorescence labeling. All proteins were only partly purified
by re-buffering to appropriate buffers. KD values from 100 nM to 5 µM were then determined with the
MST approach for different SH2 proteins, extending the results of the pull-down assay and allowing to
hypothesize on the physiological relevance of the different ADAP interaction partners. Due to the high
sensitivity of the fluorescence detection, only small amount of ADAP protein was required, showing that
the assay could be used for proteins that are hard to obtain in high yields.
In a protocol published in the journal for visualized experiments [42], a purification-free approach
was proposed for proteins expressed in cell lines. A signal transducer and activator of transcription
(STAT) protein was expressed with a fused GFP molecule in HEK293 cells. The cells were lysed in
non-denaturing conditions, and the cell lysate was diluted in physiological buffer to obtain GFP fluores-
cence intensity within the dynamic range of the MST instrument detector. Oligonucleotides of different
sequences were mixed directly into the cell lysate for the MST measurements, making the method es-
sentially protein purification-free. By adjusting the time for expression of the GFP-fused protein, one
could adjust the required dilution factor of the lysate, allowing to measure the binding interactions in
close-to-native conditions.
Binding in natural environments
As seen from the just mentioned purification-free assays, the MST method can quantify dissociation
constants in complex environments, providing access to affinity information under close-to-native con-
ditions.
This advantage of the MST approach was recognized already in the first publication on MST where
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binding between the thrombin aptamer and thrombin was measured in the selection buffer as well as in
10% and 50% human serum [3]. The presence of serum shifted the observed KD value more than 20-
fold. The same tendency towards reduced affinity in serum was shown for the above-mentioned binding
between the PKA protein and its inhibitor quercetin [96]. In that study, decrease in affinity was traced
back to the binding between the quercetin and human serum albumin.
In contrast to using serum as a solvent for the fluorescent molecule, into which the ligand is titrated,
one can use MST to perform quantitative analysis of the molecular interaction with the molecule of
interest initially present in the serum/plasma of an individual. For example, as autocompetition assay
developed by Lippok [49] was successfully used to quantify in one experiment both concentration and
affinity of the autoimmune antibody against the cardiac β1-adrenergic receptor related to dilated car-
diomyopathy. In this study, the serum containing the molecule of interest - the antibody L - was spiked
with a labeled artificial antigen - the labeled binding partner B∗ - such that all the labeled binding partner
was in the bound form B∗L: c (B∗)total = c (B∗L), where c denotes concentration. The unlabeled form of
the same binding partner B was then titrated in until it could completely compete out its labeled version:
c (B∗)total  c (B)total and c (B∗)total = c (B∗) f ree. The inflection point of the obtained binding curves re-
ported on the concentration of the antibody in serum, while the amplitude reported on the affinity of the
antibody to its antigen. As mentioned above, the limitations of this approach are its sensitivity and often
an inaccessibility of low affinity interactions.
An assay developed in this Thesis
In this part of the Thesis, I developed a new MST-based competition assay that allowed to measure effects
of both affinity and concentration of a molecule present directly in blood plasma [7]. The assay was
tested by analyzing the NE-AAT binding in blood plasma of AAT deficient individuals. The dissociation
constant of NE-AAT binding is on the order of μM. Applying the autocompetition assay introduced
by Lippok (described in the paragraph above) would have required to obtain NE in mM concentration,
which turned out to be impossible. The assay developed here managed to overcome this limitation by
using another high affinity ligand of AAT, elafin.
In short in this assay, the plasma sample that contained the molecule of interest - AAT - was first
spiked with the labeled binding partner of AAT - labeled neutrophil elastase (NE*). Differently from the
previous approach, another binding partner of AAT - elafin - known to have a higher affinity for AAT
compared to NE* was then titrated. Elafin competed out NE* and formed a complex with AAT.
The theoretical analysis of such an experimental setting showed that the amplitude of the obtained
binding curve was sensitive to both concentration of AAT and its affinity to NE*. The amplitude, being
a reporter of AAT concentration and affinity to NE*, correlated with the disease status of AAT deficient
individuals better than the concentration of AAT alone.
In the next sections of this chapter, I will first give the theoretical analysis of the experimental sys-
tem. I will then describe the experimental realization and application of the assay to the analysis of the
NE-AAT binding in blood plasma of individuals with AAT deficiency disorder. I will finally discuss
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interesting findings about the dependence of the AAT activity on the composition of the blood plasma
environment.
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6 Theoretical Considerations
Defining the system
In the competition assay introduced in this work, elafin competes for binding to AAT that is initially
partially bound to NE* and partially is free in blood plasma. To describe such system theoretically, let us
consider the chemical binding equilibrium between ligands I1 and I2 and a fluorescently labeled binder
E, where I1 is AAT in plasma, I2 is elafin, and E is the labeled elastase (Figure 11a):
E + I1 + I2 EI1 + EI2
As described in Section 5.1, the binding is observed in MST experiments as the difference in the
thermophoretic depletion of a molecule E in a free state and in the bound states EI1 and EI2. The
thermophoretic depletion of a molecule is described by its Soret coefficient S moleculeT . I assume that the
Soret coefficients of the free and bound species of the molecule E in the sample are different:
S ET , S
EI1
T , S
EI2
T
Detected fluorescence
In a typical MST experiment, the temperature in the observed spot is increased by a small ∆T = T −T0
in the range of 5-10 K, where T0 is a steady-state temperature before heating occurred and T is a steady-
state temperature upon heating of the solution. From equation 25, the steady-state concentration of a
molecule E, cE , at the position where the temperature is increased by ∆T can be found as:
cE
cE0
= e−S
E
T4T (30)
where cE0 is the concentration of a molecule E when ∆T = 0. (In Section 6, c
i
0 refers to the concen-
tration of a species i when ∆T = 0).
For small enough ∆T , Taylor expansion can be used:
cE
cE0
≈ 1−S ET4T (31)
Similarly for EI1 and EI2:
cEI1
cEI10
= e−S
EI1
T 4T ≈ 1−S EI1T 4T (32)
cEI2
cEI20
= e−S
EI2
T 4T ≈ 1−S EI2T 4T (33)
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The fluorescence detected from a sample consisting of a mixture of E, EI1, and EI2 can be expressed
as the sum of the fluorescence detected from the molecule E in free and bound states:
F = FE + FEI1 + FEI2
The detected fluorescence can further be expressed as a product of the quantum efficiency of the dye
attached to the molecule f molecule and the concentration of a particular species:
F = f EcE + f EI1cEI1 + f EI2cEI2
I assumed that quantum efficiencies of bound and unbound species are equal, because the dye on all
the species is the same:
F = f cE + f cEI1 + f cEI2 (34)
By substituting cE , cEI1 , and cEI2 in equation 34 with expressions derived from equations 31-33, the
fluorescence detected after the sample was heated by a small ∆T can be expressed as:
F(4T ) = f cE + f cEI1 + f cEI2 − ( f cE0 S
E
T4T + f c
EI1
0 S
EI1
T 4T + f c
EI2
0 S
EI2
T 4T ) (35)
Thermophoretic depletion
By definition, the thermophoretic depletion is the fraction of fluorescence detected in the heated state
and fluorescence detected in the cold state:
Depletion =
F(4T )
F(4T = 0)
(36)
By substituting F(∆T ) in equation 36with equation 35 and F(∆T = 0) with equation 34, after the
algebraic transformations, follows that Depletion is given by:
Depletion = 1− (S ET
cE0
cE0 + c
EI1
0 + c
EI2
0
+ S EI1T
cEI10
cE0 + c
EI1
0 + c
EI2
0
+ S EI2T
cEI20
cE0 + c
EI1
0 + c
EI2
0
)4T (37)
Amplitude
By definition, the amplitude of a binding curve in an MST experiment is the difference between the
thermophoretic depletion at the negligible concentration of the titrated molecule I2 (Depletionstart) and
after adding the maximal concentration of the titrated molecule I2 (Depletionend) (also Figure 11b):
Amplitude = Depletionstart −Depletionend (38)
Assuming cEI20 = 0 for Depletionstart, and c
EI2
0  c
E
0 + c
EI1
0 for Depletionend, equation 37 gives:
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Depletionstart = 1− (S ET
cE0
cE0 + c
EI1
0
+ S EI1T
cEI10
cE0 + c
EI1
0
)4T (39)
Depletionend = 1−S
EI2
T
cEI20
cE0 + c
EI1
0 + c
EI2
0
4T = 1−S EI2T 4T (40)
From equations 38-40:
Amplitude = S EI2T 4T − (S
E
T
cE0
cE0 + c
EI1
0
+ S EI1T
cEI10
cE0 + c
EI1
0
)4T (41)
The Soret coefficients S EI2T , S
E
T , and S
EI1
T are intrinsic properties of the molecules EI2, E, and EI1.
They define the behavior of these molecules in temperature gradients.
cE0
cE0 +c
EI1
0
is the proportion of free
E in steady state when only E and I1 are present in the sample. Similarly,
cEI10
cE0 +c
EI1
0
is the proportion of
complex EI1 in steady state when only E and I1 are present in the sample.
Amplitude as a function of the I1 concentration and the affinity between I1 and E
As before in Section 5.1 and equations 26-29, cEI10 can be expressed in terms of total I1, total E, and the
dissociation constant between molecules I1 and E that I denote here as K
EI1
D :
cI1 total0 = c
EI1
0 + c
I1
0
cE total0 = c
EI1
0 + c
E
0
KEI1D =
cE0 c
I1
0
cEI10
cEI10 =
cI1 total0 + c
E total
0 + K
EI1
D −
√
(cI1 total0 + c
E total
0 + K
EI1
D )
2−4cI1 total0 c
E total
0
2
Thus, cEI10 is a function of total I1, total E, and K
EI1
D :
cEI10 = f (c
I1 total
0 , c
E total
0 , K
EI1
D ) (42)
cE0 is also a function of total I1, total E, and K
EI1
D :
cE0 = c
E total
0 − c
EI1
0 = f (c
I1 total
0 , c
E total
0 , K
EI1
D ) (43)
Finally, it follows from equations 41-43 that
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Amplitude = f (cI1 total0 , c
E total
0 , K
EI1
D ) (44)
cI1 total0 refers to the total concentration of AAT in plasma, c
E total
0 refers to the total concentration
of labeled elastase NE that is being spiked into the plasma sample, and KEI1D refers to the dissociation
constant between AAT and NE in the plasma sample. The total concentration of NE used in the de-
veloped competition assay is defined by the protocol. Therefore, the Amplitude can only differ if the
total concentration of AAT in plasma samples or the affinity between AAT and NE is different between
the samples. In other words, Amplitude is sensitive to the concentration of AAT and its affinity to NE
directly in blood plasma.
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7 Experimental Realization
In the following chapter, I will describe materials that were required for the assay development, details
of the assay protocol and the binding model for simulations, and then the assay development itself on an
example of AAT-NE binding in blood plasma.
7.1 Experimental Procedures and Data Analysis
Production of the recombinant proteins
All the recombinant proteins for this project were produced by my collaborator on the project Dr. Therese
Dau associated with Comprehensive Pneumology Center, Institute of Lung Biology and Disease (iLBD),
University Hospital, Ludwig Maximilians University and Helmholtz Zentrum München. The details can
be found in the research article published based on this work [7].
Labelling of NE
The labeling was performed on the cysteine residues of the cysteine-tag of the recombinant NE protein.
First, 1 mM of reducing agent dithiothreitol (DTT) was added to the recombinant NE in storage buffer
(20 mM NaHPO4, 300 mM NaCl pH 7.4) and the NE was incubated for two hours at room temperature to
reduce all cysteine-tags. This step was important, as only reduced sulfur groups could be labeled. Then
the DTT was removed by precipitating NE with 75% ammonium sulfate. This reduction and precipitation
step was repeated once. Then, NE was re-dissolved in storage buffer, 5-fold molar excess of dye (Alexa
Fluor® 647 NHS Ester, ThermoFisher Scientific) was added, and the solution was incubated at room
temperature for one hour. To remove the excess dye, the solution was added to PD MiniTrap G-10
column (GE Healthcare) according to the manufacturer’s protocol.
Determination of the concentration of the recombinant AAT and AAT in blood plasma
The concentration of AAT in blood plasma and the concentration of the recombinant AAT were deter-
mined by my collaborator using an activity assay with an active site titrated neutrophil elastase. The
details on the assay can be found in the research article associated with this project [7]. The strong
advantage of the assay is that allowed to measure the concentration of functional AAT in blood plasma.
Development of the binding model for simulations
The mass action law equations with two dissociation constants were used to describe the dependency
of free NE (here: E) on the concentration of AAT (here: I1) and on the affinity of AAT to NE in the
presence of NE ligands AAT and elafin (here: I2) (Figure 11a):
E + I1 −⇀↽ [EI1] (45)
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E + I2 −⇀↽ [EI2] (46)
K I1D =
([E]− [EI1]− [EI2])([I1]− [EI1])
[EI1]
= [E](1− x)(
[I1]
[EI1]
−1) (47)
K I2D =
([E]− [EI1]− [EI2])([I2]− [EI2])
[EI2]
= [E](1− x)(
[I2]
x[E][EI2]
−1) (48)
where K I1D is the dissociation constant of NE-AAT interaction, K
I2
D is the dissociation constant of
NE-elafin interaction, [E], [I1], [I2] are the total concentrations of NE, AAT, and elafin in the reaction,
respectively, [EI1] is the concentration of NE-AAT complex in the reaction, [EI2] is the concentration of
NE-elafin complex in the reaction, and x = [EI1]+[EI2][E] is the fraction of occupied NE.
Equation 48 was solved for [E], which was then applied to equation 47 to yield a cubic equation for x.
The cubic equation was solved numerically in Igor Pro 5.03 and the smallest real root of the equation was
used to plot the fraction of bound NE, x, against different elafin concentrations, I2, to simulate binding
curves of the competition assay.
Determination of the binding curve amplitude
Human recombinant elafin (Sigma-Aldrich) was serially diluted (1:1) over five orders of magnitude in
phosphate-buffered saline (PBS). Separately, plasma was diluted (final concentration: 7.5% v/v) in stor-
age buffer substituted with 0.02% Tween 20 and anti-photobleaching enzyme and substrate components
(Monolith Anti Photobleach Kit, NanoTemper Technologies) were added. This plasma solution was
mixed 1:1 with PBS for background measurements. After adding fluorescently labeled NE (final con-
centration: 500 pM) to the plasma solution, it was mixed 1:1 with each concentration of the serial dilution
of elafin. The samples were loaded into the Monolith™ NT.115 premium coated capillaries (NanoTem-
per Technologies) and incubated at 22°C for 2 hours. The samples were measured in the instrument
(Monolith NT.115Pico, NanoTemper Technologies) at 22°C using 60% light-emitting diode and 40% in-
frared laser (IR) powers with IR laser on/off times of 25/5 seconds. Each dilution point was measured in
triplicates. For each plasma sample, the whole procedure was repeated three times to yield independent
triplicates.
In MATLAB, the time trace of the background signal was subtracted from the time traces of the
sample signals. Then, the fluorescence after the temperature jump and equilibrated thermophoresis was
normalized to the fluorescence before the IR laser heating, yielding fluorescence depletion values. Fluo-
rescence depletion values of three technical replicates (mean ± S.D.) were plotted in per mille units (‰)
on a linear y-axis against the concentration of the serially diluted elafin on the log10 x-axis resulting in
binding curves. The binding curves were shifted so that the depletion values at the baseline where elafin
concentration is saturating were the same. Several example binding curves are shown in Figure 11b.
To yield the amplitude A of each curve, a weighted with standard deviation fit was performed to the
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solution of the quadratic equation that describes binding between two species (based on equation 29):
f (x) = A
[E] + x + KD−
√
([E] + x + KD)2−4[E]x
2[E]
+ t (49)
where KD is the dissociation constant of NE-elafin interaction, [E] is the total concentration of NE,
x is the total concentration of elafin, A is the amplitude of the curve, t is the y-offset of the curve, with A,
t, and KD as free fit parameters. The fitting was performed in Igor Pro 5.03.
Determination of the dissociation constant between AAT and NE
The amplitude from the competition binding assay is sensitive at the same time to AAT affinity to NE
and AAT concentration. In order to quantify only the AAT affinity to NE in a plasma environment, the
standard MST assay was also performed with purified AAT as follows. Freshly purified AAT was serially
diluted (1:1) over five orders of magnitude in the storage buffer. Separately, plasma was diluted in the
storage buffer substituted with 0.2% Tween 20 (final plasma concentration: 7.5% v/v) and anti-bleaching
reagents were added. This plasma solution was mixed 1:1 with the storage buffer for background mea-
surements. Fluorescently labeled NE (final concentration: 5 nM) was added to the plasma solution and
mixed 1:1 with the serial dilution of AAT. The samples were incubated for 2 hours at 22°C and mea-
sured at 22°C in the instrument using 40% light-emitting diode and 40% infrared laser (IR) powers with
IR laser on/off times of 20/5 seconds. Binding curves were obtained as described in section 7.1. They
were then additionally normalized to 0 for the lowest AAT concentration and to 1 for the highest AAT
concentration. Binding curves normalized this way display the proportion of bound NE at each titration
point. Such curves are shown for example in Figures 13-14. The global fit of at least three replicates to
equation 49 was performed to yield the dissociation constant of each curve.
Plasma samples and FEV1 data
Many AAT-deficient patients suffer from or are predisposed to develop lung emphysema and chronic
obstructive pulmonary disease. In clinics, the lung function is assessed by the volume of air that can
be forcibly exhaled during 1 second. This parameter is called the forced expiratory volume in 1 second
or FEV1. It is expressed as the percentage (%) predicted for age, sex, height, and race. All plasma
samples and the FEV1 values data were kindly provided by the collaborator Prof. Rob Stockley in Lung
Investigation Unit, Queen Elizabeth Hospital Birmingham, UK.
Statistical analysis
Results are given as median values. A Mann-Whitney test without assuming Gaussian distribution was
applied to all studies (***p<0.001). Statistical analysis was done with GraphPad Prism 6 software
(GraphPad Software).
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7.2 Assay development
In the competition assay, a low affinity inhibitor I1 (here: AAT) competes with a high affinity inhibitor
I2 (here: elafin) for the catalytically inactive labeled enzyme E (here: NE) (Figure 11a). Inactivation
of E was important to prevent the removal of I1 from the equilibrium by the irreversible formation of a
covalent complex.
The labeled E at a fixed final concentration of 500 pM was mixed with a 12-fold diluted plasma
containing the molecule of interest I1. To obtain binding curves, increasing amounts of I2 were added
and thermophoretic depletion of free E and E bound to I1 (EI1) or I2 (EI2) was measured for each
concentration of I2 (Figure 11a, b). From the obtained binding curves, one can observe that the depletion
in the low end range of I2 concentrations varied between plasma samples while the depletion in the high
end range of I2 concentrations did not change (Figure 11b). Thus, the amplitude of the binding curves
varied between plasma samples (Figure 11b). This led to the hypothesis that I1 concentrations and, more
importantly, I1 affinities to E are not necessarily constant in the person-specific complex environments
of blood plasma (Figure 11b).
To characterize the system at different affinities between I1 and E (Figure 11c) and different I1 con-
centrations (Figure 11d), the system was described with mass action law equations and the corresponding
binding curves were simulated as described in Section 7.1. The simulation results indicate that the ampli-
tude increases with an increasing KEI1D (Figure 11c, small insertion graph) and decreases with increasing
I1 concentrations (Figure 11d, small insertion graph). Hence, the amplitude reports on both I1 concen-
tration and KEI1D as described mathematically in Section 6.
Analysis of the amplitude
The amplitude is defined as the difference between minimal and maximal depletion signals in the low
and high end ranges of I2 concentrations, respectively (Figure 11b). To get an intuitive understanding of
what the amplitude of the binding curve in the introduced competition assay depends on, let us analyze
the theoretical equilibrium for both situations separately in more detail.
In the low end range of I2 concentrations, interactions between I2 and E are almost non-existent.
Therefore, the proportion of bound E depends solely on its interaction with I1 (Figure 11b, dark grey
box on top of the graph). The proportion of bound E at this point is a function of both, the concentration
of I1 as well as the dissociation constant between E and I1 (K
EI1
D ) in plasma. Higher concentrations
of I1 shift the equilibrium towards EI1 complexes, while a higher K
EI1
D results in a decrease of EI1
complexes (Figure 11a, dark grey box on top of the graph). The thermophoretic depletion of I1-bound E
is considerably larger than that of the free E. Hence, the measured thermophoretic depletion reflects the
proportion of E bound to I1 in the mixture that varies between the plasma samples.
At maximal concentration of I2, all E is bound to I2 independent of the other parameters due to the
high affinity between E and I2 (Figure 11b, light grey box). The thermophoretic depletion is the depletion
of EI2 complexes and is the same for all the plasma samples and only depends on the amount of labeled
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Figure 11: Dependency of the amplitude on the AAT concentration and the dissociation constant of
NE-AAT binding.
(a) The theoretical background of the method. At each data point, the inhibitor I1 (here: AAT) competes
with I2 (here: elafin) for the enzyme E (here: labeled inactive NE). The affinity between E and I2 is
much higher than the affinity between E and I1. (b) To a constant amount of plasma (7.5%) containing I1
and a constant amount of E (500 pM) increasing concentrations of I2 were added and the thermophoretic
depletion measured. Titration curves with theoretical fits are given for three individuals homozygous
for the Z-variant AAT (patients 1, 8 and 10) as examples. Each depletion value is given as mean ±
S.D. from three technical replicates. The amplitude is defined as the difference between the minimal
depletion signal in the low end range (dark grey box with arrow) and maximal depletion signal in the
high end range of I2 concentrations (light grey box with arrow). The thermophoretic depletion of free E
is smaller than that of E bound to I1 or I2, and depletion at each I2 concentration indicates the proportion
of bound E. (c) and (d) Simulations according to the mass action laws. (c) shows that the theoretical
amplitude (simulated as the amount of bound E) increases when the dissociation constant between E and
I1 increases. (d) shows that the theoretical amplitude decreases with the increasing concentrations of I1.
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Figure 12: Amplitude, but not plasma concentration of AAT correlates with disease severity.
(a) ZZ-carriers (n = 26) were divided into two groups with high FEV1 (≥ 80%, n = 8) and low FEV1 (<
80%, n = 18), which is a clinical parameter of airway obstruction. The amplitude was significantly lower
(P = 0.0008) in samples with high FEV1 (***P<0.001; ns not significant). The amplitude is given as a
mean value determined from at least two independent experiments. (b) The concentration of functional
AAT was not significantly different (P = 0.64) between the groups with high FEV1 (≥80 %) and low
FEV1 (< 80%). The AAT concentration was measured twice by elastase titration in duplicates, and is
given as a mean value here.
probe E spiked into a sample. Thermophoretic depletion of I2-bound E is also considerably larger than
that of the free E.
Taken together, the amplitude depends on the proportion of I1-bound E in the sample at I2 concen-
trations approaching zero. The largest amplitude is obtained when all E is free at lowest I2 concentration
in equilibrium. Accordingly, the amplitude decreases with decreasing KEI1D values and increasing I1
concentrations (Figure 11c, d, smaller insertion graphs).
7.3 Amplitude and disease status
To evaluate whether the amplitude, which reports on AAT concentration and AAT affinity variations,
represents a better lung function parameter than AAT concentration alone, both parameters were deter-
mined in plasma samples of individuals homozygous for the AAT Z-variant as described in Sections 7.1
and 7.1. They were then compared to FEV1 values (Section 7.1). FEV1 values allow to assess the lung
function in AAT-deficient individuals [5, 83].
Comparison of the correlations between the AAT concentration and FEV1 and the amplitude and
FEV1 showed that a significantly lower amplitude (P=0.0008) was observed for plasma samples from
individuals with high FEV1 (≥ 80%) than from those with low FEV1 (< 80%) (Figure 12a). The concen-
tration of functional AAT did not differ between the two groups (P = 0.64) (Figure 12b). Hence, inclusion
of affinity with the introduced assay resulted in a much better correlation to disease status and severity.
To explain the discrepancy between the quantifying just the concentration and a parameter sensitive to
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Figure 13: Plasma-dependent change in affinity of NE-AAT binding.
The dissociation constants of the interaction between AAT and NE in two plasma pools from individuals
with high FEV1 (≥ 80%, n = 8) and low FEV1 (≤ 50%, n = 12) were compared. The affinity between Z-
variant of AAT and NE was higher in plasma with high FEV1 (≥ 80%) (KEI1D = 500 ± 100 nM) compared
to the affinity in low FEV1 (≤ 50%) (KEI1D = 1300 ± 250 nM). The presented binding curves represent
example measurements where each measurement point (mean ± S.D.) was averaged from three technical
replicates. The fitted binding curves and KEI1D values (mean ± S.D.) were derived from global fitting of
four measurements (three independent protein expressions). The measurements were performed in 7.5%
plasma and with 5 nM of labeled NE.
concentration and affinity, it was reasoned that KEI1D of the Z-variant is in fact varied between the plasma
samples.
7.4 Sensitivity of Z-variant AAT to plasma environment
To investigate whether affinity is indeed sensitive to a given plasma environment, the KEI1D value of the
AAT Z-variant binding to NE in two AAT-deficient plasma pools from persons with high (≥ 80%) and
low FEV1 (≤ 50%) values was determined (Figure 13).
To facilitate the recombinant production of the aggregation-prone Z-variant, three stabilizing muta-
tions derived from the work of [46] – Met374Ile, Ser381Ala, Lys387Arg – were introduced into the AAT
sequence. As a control, AAT without the Z-mutation but containing the same stabilizing mutations was
also expressed.
The affinity of the Z-variant to NE was more than two times better in the plasma pool from individuals
with high FEV1 (≥ 80%) (KEI1D = 500 ± 100 nM) than from individuals with low FEV1 (≤ 50%) (K
EI1
D
= 1300 ± 250 nM), confirming the plasma-dependent change in the affinity between NE and Z-variant
AAT as observed with the developed assay.
Additionally, it was shown that the Z-mutation improves the encounter reaction of AAT with NE
(Figure 14a) and Z-variant AAT is more susceptible to plasma components than control AAT (compare
Figure 13 and Figure 14b).
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Figure 14: Z-variant AAT is more susceptible to plasma-dependent changes than AAT without Z-
mutation.
(a) In high FEV1 (≥ 80%) plasma pool, affinity between the stabilized Z-variant of AAT and NE (KEI1D
= 500 ± 100 nM) was approximately five times better than between the stabilized AAT without Z-
mutation and NE (KEI1D = 2760 ± 550 nM). The fitted binding curves and K
EI1
D values (mean ± S.D.)
were derived from global fitting of four measurements (three protein expressions) with Z-variant of AAT
and three measurements (three protein expressions) with AAT without Z-mutation. (b) There was no
significant difference between the affinity of the stabilized AAT to NE in high FEV1 (≥ 80%) (KEI1D =
2760 ± 550 nM) and low FEV1 (≤ 50%) (KEI1D = 2540 ± 300 nM) plasma environments. The fitted
binding curves and KEI1D values (mean ± S.D.) were derived from global fitting of three measurements
(three protein expressions) in high FEV1 plasma and four measurements (two protein expressions) in low
FEV1 plasma. The measurements were performed in 7.5% plasma and with 5 nM NE. The presented
binding curves represent example measurements where each measurement point (mean ± S.D.) was
averaged from three technical replicates.
8 Discussion and Outlook
In this project, I worked on developing an assay for analyzing concentration and affinity effects of a
disease-relevant molecule present directly in human plasma samples. The assay is based on the bio-
physical technology of microscale thermophoresis that allows to separate molecules based on their ther-
mophoretic mobility directly in human plasma solution. Analysis performed directly in the plasma sam-
ple allowed to take into account effects of different plasma components on the affinity of the interaction
between the molecules of interest.
By incorporating a high affinity ligand in thermophoretic measurements, this work expanded the
spectrum of applications towards the low affinity range where e.g. enzyme-substrate interactions take
place. This new approach allowed to detect unexpected plasma-dependent interferences with AAT. These
interferences suggest that the functioning of the Z-variant AAT depends on various plasma components
that can modulate the affinity of AAT towards target enzymes. For example, it was reported [26, 87]
that lipoproteins can bind to wild-type AAT, thereby influencing its inhibition of NE. Thus, lipoproteins
present in the plasma environment could be suspects for affecting the reactivity of the Z-variant AAT.
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Figure 15: Functional differences between two M1 AAT variants in lipid-containing vs in lipid-free
plasma.
Adopted from [53] (a) In the presence of lipids, the affinity NE binding to M1(A213) AAT (KD =
3200 ± 50 nM) was substantially higher than the affinity of NE binding to M1(V213) AAT (KD =
6800 ± 1000 nM). (b) In the absence of lipids, there was no observable difference between the affin-
ity of NE binding to M1(A213) AAT (KD = 540 ± 50 nM) or NE binding to M1(V213) AAT (KD =
550 ± 60 nM). Fitted binding curves and KD values (mean ± S.D.) were derived from global fitting
of three measurements (three independent protein expressions). The measurements were performed in
7.5% plasma and with 5 nM NE. Presented binding curves represent example measurements where each
measurement point (mean ± S.D.) was derived from three technical replicates.
Possible explanation for variability of symptoms in ZZ carriers The analysis of the interaction
between the Z-variant AAT and NE in plasma with the introduced assay provides a possible explanation
of the variability in disease development in ZZ carriers. Normally, the reduced AAT plasma levels in
ZZ carriers are compensated by the enhanced affinity of Z-variant AAT to NE (Figure 14a). However,
the enhanced affinity between Z-variant AAT and NE can be disrupted by plasma factors (Figure 13),
especially in individuals who have higher concentrations of the interfering plasma components.
Extending the developed technique to a different project I took part in a different project where I
measured the dissociation constant of AAT-NE binding in lipid-containing plasma vs in lipid-free plasma
[53] for two other variants of AAT, the minor M1(A213) allele and the prevalent M1(V213) allele of AAT.
The co-authors on this study found that M1(A213) AAT associates with large artery atherosclerotic stroke
condition, however, no functional differences between the two alleles were found in the previous studies
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where the affinity was tested in simple buffer systems [60]. For testing whether there is a functional
difference between the two alleles interacting with NE within a complex matrix of plasma, the lipid-free
plasma and proteins were prepared by my collaborator, Therese Dau [53], and the MST binding assay was
performed as explained in Section 7.1. I saw that the M1(A213) variant had an almost two-fold higher
affinity towards NE (KD = 3200 ± 50 nM) compared to M1(V213) variant (KD = 6800 ± 1000 nM) in the
lipid-containing plasma (Figure 15a). The difference was not detectable in the lipid-free plasma (Figure
15b) with KD values of (540 ± 50) nM and (550 ± 60) nM for M1(A213) and M1(V213) variants,
respectively. The affinity of interaction between NE and AAT was enhanced for both variants in the
lipid-free plasma. This experiment confirmed that plasma components play a crucial role when studying
intermolecular interactions. This result also supports the idea that the lipoproteins present in plasma
could affect the affinity of the Z-variant AAT to NE in the context of the AAT-deficiency disorder.
The results of the work presented in this part of the Thesis underscore the importance of the per-
sonally unique and distinct endogenous environments where enzymes interact with their substrates in a
complex web of other components including proteins and lipids. The effects of such highly personalized
environments have often been overlooked due to the absence of appropriate techniques. Therefore, the
approach developed in this work may open a door to study how the components of native environments
where interactions take place interfere with known biochemical reactions and could allow to discover
new surprising elements in these reactions.
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The genetic code The genetic code describes a set of rules that define which amino acids are encoded
by which codons (sequences of three nucleobases) during the translation of RNA into proteins in the
cells. It is, therefore, an essential mechanism of all life. The genetic code defines the mapping of 64
codons to 20 naturally occurring amino acids (Figure 16a). The code is highly conserved and is shared
with only minor modifications by all known life forms on Earth [19].
The genetic code is highly nonrandom [20]. Specifically, the codons are clustered based on the
properties of the amino acids. Amino acids that share a biosynthesis pathway tent to have the same first
letter of the code [88]. Amino acids of the shikimate, pyruvate, aspartate, and glutamate pathway families
tend to have at the first positions of their codons bases U, G, A, and C, respectively. This connection to
the synthesis pathway could indicate that a more simple code with less amino acids had existed first and
was extended to a larger set of amino acids by assigning new amino acids to the codons that were similar
to the codons of the precursor amino acids.
Figure 16: The genetic code and the tRNA.
(a) One of the representations of the genetic code. (b) The cloverleaf representation of the sec-
ondary structure of the tRNA molecule (modified from https://en.wikipedia.org/wiki/Transfer_RNA).
“m” stands for methylation, “D” stands for 5, 6-Dihydrouridine, “Ψ” stands for pseudouridine, “Y”
stands for wybutosine, and “p” stands for a phosphate group.
Amino acids of similar physiochemical properties, such as polarity and the structure of the side chain,
also have similar codons [8, 12]. This property of the genetic code could help to minimize the deleterious
effects of mistranslations and point mutations on the outcome of protein synthesis. The overall code in
general was shown to be optimized to minimize the likelihood of mistranslations and point mutations
[21].
Another perplexing property of the genetic code is a negative correlation between the molecular
weight of the amino acid and the number of cognate codons encoding the amino acid [11]. This suggests
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that early amino acids, which had a chance to establish the largest codon plurality, were simple and, thus,
had side chains of smaller molecular weights.
Amino-acyl tRNA synthetases In modern cells, the assignment of amino acids to their codons is
executed by an enzyme, amino-acyl tRNA synthetase (aaRS) in several steps. aaRS first binds ATP and
the corresponding amino acid (or its precursor) to form an aminoacyl-AMP (amino acid bound to AMP,
or aa-AMP), releasing the inorganic pyrophosphate (PPi). The complex of aaRS and aa-AMP then binds
the appropriate transfer RNA molecule (tRNA, Figure 16b) and the amino acid is transferred from the
aa-AMP to either the 2’- or the 3′-OH of the last tRNA nucleotide (A76) at the 3′-end.
1. amino acid + ATP → aa-AMP + PPi
2. aa-AMP + tRNA → aa-tRNA + AMP
aaRS is a complex enzyme that recognizes the correct tRNA based on several tRNA sequence and struc-
ture signatures, including the codon loop and the acceptor stem of the tRNA. Interestingly, in some cases,
the codon loop is not important for a correct charging of the tRNA by a corresponding aaRS (reviewed
in [74]). A complex recognition process between tRNAs and aaRSs could only exist once a reliable
copying of ∼ 70 bases long RNA strands have evolved, which, as discussed in Part I of this Thesis, is
not a trivial evolutionary invention. Therefore, the complex system of coded protein synthesis must have
evolved from a more primitive version.
Theories on the origin of the genetic code So how did the system of coded protein synthesis evolve,
or what is the origin of the genetic code? An idea that the genetic code was the result of a “frozen”
accident was introduced by Crick in 1968 [6]. In his hypothesis, the early assignments of tRNA-like
ribozymes and amino acids were established randomly. Once functional peptides could have been pro-
duced from amino acids encoded in this early genetic code, any random change would have been lethal
to the organism. Thus, the code became “frozen”. However, the high degree of structure found in the
genetic code made researchers suggest more function-related theories of the origin of the genetic code,
including the adaptive theory, the coevolution theory, and the stereochemical theory.
The adaptive theory states that the code was developed under the selective pressure that made the code
optimized against translational and mutational errors [21]. The coevolution theory postulates that the
code’s structure reflects the amino acids’ biosynthesis pathways, and evolved in parallel with them [99].
Both theories do not deal with the question, how the very first assignments between primordial amino
acids and their codons were established. This gap is covered by the stereochemical theory that posits that
specific assignments were established based on the specific stereochemical interactions between amino
acids and their cognate codons [30, 103]. All three theories do not have to be exclusive but could hold true
for different amino acids’ assignments and periods in evolution. The early amino acids could have been
assigned based on their stereochemical properties, while the newer additions to the genetic code could
have been assigned based on the similarity of their biochemical pathway to already existing amino acids.
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The code could have additionally been checked by natural selection to be robust against mistranslations
and point mutations. Especially the last mechanism could have modified the early “original” genetic
code hiding its early signatures.
In this project, I focused on the stereochemical theory of the origin of the genetic code. The idea
behind the stereochemical theory is to consider the early translation mechanism as being enzyme-free,
and thus to remove aaRS as a player from the story. The question is then, could have a primordial tRNA
itself executed the function of recognizing the correct amino acid? And could have this recognition
been mediated by the intrinsic stereochemical interactions between the amino acid and the codon in the
sequence of this primordial tRNA?
So far, the stereochemical theory was mainly tested in numerous SELEX experiments, where oligonu-
cleotides were selected to have an amino acid specific binding affinity. Selected aptamers showed en-
richment in amino acid specific codons/anticodons [101]. However, SELEX experiments suffer from
sequence biases and accumulate PCR artifacts; additionally, significance of the enrichment depends on
the applied statistical analysis showing the weaknesses of the experimental approach (reviewed in [44]).
A more direct approach would be to measure experimentally the binding affinity between the codons and
amino acids.
Project goals The goal of this project was to device new experimental systems for testing the stereo-
chemical theory of the origin of the genetic code and to lay the groundwork for future research on the
topic. This was done with two approaches.
1. In one approach, an AMP-binding RNA aptamer was chosen and used as a testbed to measure
binding affinities of amino acids modified with AMP to the aptamer modified to contain different
codons/anticodons within its sequence.
2. In the other approach, two hypotheses for the structure of the primordial tRNA were taken from
literature (Hopfield and Rodin hypotheses [30, 68]) and used to test their binding affinities to amino
acids modified with AMP.
Primordial amino acids Not all 20 naturally occurring amino acids were likely a part of the early
genetic code. Pudritz and Higgs identified amino acids glycine (Gly), alanine (Ala), aspartate (Asp), glu-
tamate (Glu), valine (Val), serine (Ser), isoleucine (Ile), leucine (Leu), and proline (Pro) as prebiotically
plausible by systematizing various experiments on prebiotic amino acid syntheses, including hydrother-
mal synthesis, synthesis in icy grains, amino acids brought my meteorites, atmospheric synthesis, and
other types of synthesis [29]. To these 9 amino acids Arg was added. Arg in SELEX experiments gen-
erated aptamers often enriched in Arg codons [102]. Also Arg is a highly charged amino acid, which
makes it plausible to expect Arg to build non-covalent bonds with nucleic acids.
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Figure 17: Structures used for analyzing binding affinities.
(a) Stable phosphoramidate form of an activated amino acid. Val-AMP is shown as an example. (b)
Secondary structure of the AMP-binding RNA aptamer used for affinity measurements in this project.
Bases essential for AMP binding are circled. Dashed lines indicate hydrogen bonds that coordinate AMP
binding. In pink are the non-essential for binding bases that were modified to be codons/anticodons for
different amino acids. (c) Rodin type pre-tRNA structure. In pink are the positions that Rodin considered
to be coding for amino acids in the early days of coded translation. (d) Hopfied’s hypothesis of how the
pre-tRNA might have looked like. Just a few mutations and cutting the modern tRNA along the red line
lead to refolding of a modern tRNA such, that the anticodon and the amino acid are brought close in
space.
aminoacyl-AMPs As discussed above, aaRSs use aa-AMP molecules when charging tRNAs with
amino acids, making aa-AMP an important intermediate. aa-AMPs are, however, highly unstable in
aqueous environments being subjected to fast hydrolysis. aaRSs reaction center shields the aa-AMP in-
termediate from water and thus stabilizes it against hydrolysis. On the watery early Earth, on the other
hand, the aa-AMP intermediates would have been subjected to fast hydrolysis. Whether or not aa-AMP
were intermediates in the primordial translation system is debatable [50]. However, different stabilized
versions of aa-AMPs exist. I used a stable phosphoramidate version of the AMP-activated amino acids,
where the AMP moiety is attached to the N-end of the amino acid instead of to the C-end. This construct
occurred as a natural product in an EDC-assisted polymerization reaction performed by Richert’s group
[36].
AMP-binding RNA aptamer To test the influence of the amino acid properties on the codon prefer-
ence, literature was searched for a known AMP-binding RNA aptamer. The idea behind the search was
the following: The aptamer should stably bind the AMP moiety of the aa-AMP. This would allow to
test the preference of the amino acid part of the aa-AMP for codons introduced into the sequence of the
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aptamer by mutating nucleotides that are nonessential for AMP binding.
The AMP-binding RNA aptamer that has an adenosine binding motif of 11nt in length was selected
from literature [13, 72]. This motif was reproducibly isolated in different experiments starting from
random sequence pools [71], suggesting it is a rather simple binding structure. Additionally, several ap-
tamers with the same 11nt-long adenosine-binding motif were identified in humans in functional struc-
tures that sense ATP concentration [95]. Therefore, it is plausible that the motif could have evolved as
an adenosine-binding RNA motif early in evolution.
Primordial tRNA hypotheses For testing binding affinities to hypothetical pre-tRNA structures, two
hypothesis were selected from literature. Rodin observed that the two tRNAs with complementary anti-
codons in the anticodon loops tend to have complementary second bases in the acceptor stems [67, 69].
He hypothesized that the code evolved in complementary pairs and was originally encoded in the 1-2-3
and 70-71-72 bases of the acceptor stem. The anticodon present in the anticodon loop of the modern
tRNA has evolved later together with the tRNA evolution. The idea that the genetic code was first en-
coded in the acceptor stem was also suggested by the earlier experiments with the truncated tRNAs and
truncated aaRSs. tRNAs truncated to acceptor mini-helix could be correctly charged with the corre-
sponding amino acids. aaRSs truncated so that they couldn’t probe the anticodon loop of the tRNA, still
could place an amino acid on the correct tRNA with the same rate as before [75]. From the phylogenetic
trees for Bacteria, Archaea, and Eukarya, Rodin reconstructed the common ancestor of the acceptor stem
[67], which is a pre-tRNA of Rodin’s type (Figure 17c). The coding bases according to Rodin’s hypoth-
esis are highlighted in red and are located in close proximity to the NCCA-3′ tail, where amino acid is
supposed to attach. The pre-tRNA of Rodin’s type was experimentally analyzed in this project.
Another pre-tRNA structure was proposed by Hopfield in 1978 [30]. He noticed that just a couple
of mutations to the sequence of the modern tRNA leads to refolding of the tRNA into a Hopfield’s pre-
tRNA, where the acceptor stem and the anticodon loop are brought into close proximity. Therefore, the
amino acid binding site appears close enough to the anticodon loop to allow to imagine that the amino
acid could have been preselected by noncovalent binding to the anticodon sequences, followed by the
attachment to the 3′-end of the acceptor stem. This way aaRSs only became important for recognition
later, once the tRNA structure evolved to a modern version with the anticodon loop and the acceptor stem
far apart.
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10 Experimental Realization
10.1 Materials and Methods
Materials
Buffers All experiments were performed in 20 mM Tris at pH 7.6 (adjusted with NaOH) supplemented
with 300 mM NaCl and 5 mM MgCl2. Nuclease-free components were purchased from Ambion. Only
nuclease-free water from Ambion was used in all experiments.
DNA oligonucleotides All DNA oligonucleotides were purchased from biomers.net GmbH with HPLC
purification. Aptamer sequence with Val codon in bold: Cy5 - 5′ - GGG AAG GGA AGA GUC UGC
GGC UUC GGC CGG CUU CCC. Two strands required for Rodin’s pre-tRNA with Gly and Pro codons
in bold: 5′ - GGG GCC G-3′ and Cy5 - 5′ - CGG CCC CAC CA - 3′. Two strands required for
Hopfield’s-like pre-tRNA with Gly codon in bold: 5′ - GGG UGG GGG GGG - 3′ and Cy5 - 5′ - CCC
CCC CCA - 3′.
Amino acids and AMP L-Val, L-Gly, and AMP were purchased from Sigma. Val-AMP and Gly-AMP
were synthesized and kindly provided by the lab of Prof. Clemens Richert.
Microscale Thermophoresis Experiments
MST was introduced in detail in Sections 5.1-5.3. Here, only the details to the experiments performed in
Part III are described.
AMP, amino acid, or aa-AMP (ligands) were serially diluted (1:1) over five orders of magnitude in
the buffer. Separately, a fluorescently labeled RNA structure was diluted to the final concentration of
10 nM in the the same buffer substituted with 0.2% of Tween 20 and mixed 1:1 with the serial dilution
of the ligand. The samples were measured at 22°C in the instrument using 10% light-emitting diode
power and various infrared laser (IR) powers (mentioned in the caption to each figure containing the
experimental data) with IR laser on/off times of 25/5 seconds.
To obtain binding curves, the fluorescence after the temperature jump and equilibrated thermophore-
sis was normalized to the fluorescence before the IR laser heating, yielding fluorescence depletion values.
Fluorescence depletion values of three technical replicates (mean ± S.D.) were plotted in per mille units
(‰) on a linear y-axis against the concentration of the serially diluted ligand on the log10 x-axis result-
ing in binding curves. In some cases where the baseline for the bound state could be clearly observed,
the depletion values were additionally normalized to 0 at the lowest ligand concentration and to 1 at the
highest ligand concentration. The fit to equation 49 (Part II) was performed to yield the dissociation
constant of each curve.
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Figure 18: Preliminary affinity measurements between the AMP-binding aptamer and AMP, Gly, or
aa-AMP ligands.
The crystal structure of the original AMP-binding RNA aptamer with AMP in the binding pocket (PDB:
1raw) in shown on the top. The bases colored in blue are the ones that were mutated. The graph
displays the binding curves from the MST experiments (with 40% of the IR laser power). AMP, Val-
AMP (two different synthesis batches), Gly-AMP, or Val were titrated against the constant concentration
of the aptamer. For the experiment, the original aptamer was modified to include the Val codon (pink
letters) and was labeled on the 5′-end with Cy5 dye. The error bars are standard deviations from three
technical replicates of each experiment. Two experiments with two different synthesis batches of Val-
AMP highlight the reproducibility of the MST approach.
10.2 Results and Discussion
A simple aptamer as a testbed
To make a first experimental step towards testing whether there is an intrinsic affinity between the
codons/anticodons and the corresponding primordially plausible amino acids, the AMP-binding RNA
aptamer with Cy5 dye at the 5′-end was synthesized for MST experiments. The three bases unimportant
for AMP binding were modified to match the Val codon “GUC” (Figure 18, pink bases in the structure on
the right). Before the experiments, the aptamer was melted at 95ºC for 2 minutes and allowed to slowly
cool down to adapt the lowest energy conformation.
AMP (8 mM final highest concentration) or Val (100 mM final highest concentration) were titrated
against the constant concentration of labeled aptamer (10 nM final concentration). The dissociation
constant of 14± 3 μM was obtained for AMP binding, while Val showed no detectable binding (Figure
18). This result was expected as, according to our hypothesis, amino acids by themselves do not have a
high enough affinity for binding. However, aa-AMPs can first bind the structure due to the presence of
AMP, and then the amino acid part can build additional non-covalent bonds with the aptamer. The idea
is that if there is an enhanced affinity of amino acids to their codons/ anticodons, the affinity of aa-AMP
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Figure 19: Preliminary tests of the Rodin’s hypothesis.
(a) Selected Rodin type pre-tRNA with Gly and Pro codons at the coding positions. One of the strands
was labeled with Cy5 dye at the position far away from the expected binding site. (b) The binding curves
from the MST experiments (with 60% of the IR laser power). AMP, Gly, or Val were titrated against
the constant concentration of the Rodin’s pre-tRNA (10nM). The error bars are standard deviations from
three technical replicates of each experiment.
to the aptamer with the corresponding codon/anticodon would be stronger than to the aptamer with any
other codon/ anticodon.
To try this idea, Val-AMP (0.8 mM or 3.2 mM final highest concentration, two different Val-AMP
syntheses) or Gly-AMP (0.8 mM final highest concentration) were titrated against the constant concen-
tration of labeled aptamer (10 nM final concentration). The average dissociation constant of 42± 4 μM
was obtained for Val-AMP binding, while Gly-AMP bound with the the dissociation constant of 71± 8
μM (Figure 18). Two binding curves for Val-AMP binding from two different synthesis batches of Val-
AMP are shown to emphasize the reproducibility of the synthesis quality and the affinity measurement
method. Here, Val-AMP bound indeed with the higher affinity than Gly-AMP, in correspondence with
the Val codon “GUC” and not Gly codon “GGC” present in the aptamer sequence.
This proof of principle experiment suggests that the high affinity AMP-binding RNA aptamer could
be a good system to start testing for signatures of the genetic code. A high-throughput approach to affinity
measurements has to be implemented to be able to screen the binding between all the 10 selected amino
acids (Section 9) to all the possible aptamers with various corresponding codons/anticodons. Especially
considering that, due to the degeneration of the genetic code, more than 20 codons/anticodons correspond
to the 10 selected amino acids. Also, to decrease the costs for the synthesis of labeled RNA strands,
instead of labeling the aptamer strand itself, the 3′- or the 5′-end of the aptamer can be elongated to
allow binding of a short labeled complementary oligonucleotide. This short oligonucleotide will be the
only required labeling strand for all the aptamers with various codons/anticodons used for screening.
Rodin’s hypothesis
To test Rodin’s hypothesis of the pre-tRNA structure, Rodin’s pre-tRNA with codons for Gly and respec-
tively Pro was synthesized. One of the strands was labeled with Cy5 for detection (Figure 19a). The
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Figure 20: Preliminary tests of the Hopfield’s hypothesis.
(a) The RNA structure with an overhang of three bases at the 5′-end and the CCA sequence at the 3′-end
of the stem overlooking the overhang. The structure was used as an approximation to the Hopfield’s pre-
tRNA. One of the strands was labeled with Cy5 dye at the position far away from the expected binding
site. (b) The binding curves from the MST experiments (with 80% and 60% of the IR laser power for
binding to AMP and Gly, respectively). AMP or Gly were titrated against the constant concentration of
the RNA structure from (a). Or AMP was titrated against the fully double-stranded RNA fragment with
“C”s at the positions opposite of “G”s in the overhang. The measured dissociation constant for AMP to
Hopfield’s-like pre-tRNA binding was quantified to be 24±4 mM. The error bars are standard deviations
from three technical replicates of each experiment.
strands were mixed together at an equimolar concentrations and allowed to slowly anneal. The binding
of such a structure (at 10 nM final concentration) to Gly or Pro was tested with titrated amino acids
reaching final highest concentrations of 100 mM for Pro and 500 mM for Gly. No detectable binding
was observed (Figure 19b).
Binding to the aa-AMP molecules should be tested next. However, as AMP by itself did not show
any binding to the Rodin’s pre-tRNA (Figure 19b), the expectation is that aa-AMPs will not show any
binding either. According to our hypothesis, AMP is the guiding moiety of aa-AMP, which brings an
amino acid to its potential binding site. If the amino acid moiety corresponds to the codon of the pre-
tRNA structure, the affinity of aa-AMP could be enhanced compared to the binding of AMP alone. But
if AMP does not bind, then aa-AMP would probably also show no binding.
Hopfield’s hypothesis
For preliminary tests of Hopfield’s hypothesis of the pre-tRNA structure, Hopfield’s pre-tRNA-like struc-
ture with the codon for Gly was synthesized (Figure 20a). The codon was placed in the 3-bases overhang
at the 5′-end of one of the strands. The other strand was labeled with Cy5 for detection at the position
far away from the codon. The CCA sequence on the labeled strand corresponded to the CCA 3′-end tail
of the modern tRNA.
MST experiments for the RNA structure and Gly alone didn’t reveal any significant binding (Figure
20b). Binding to AMP provided a more interesting case. AMP bound to the overhang with the dissocia-
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tion constant of 24±4 mM in the presented experiment (Figure 20b) but affinities measured in repeats of
the experiment ranged between 2 and 25 mM. The disperse value is probably the result of the difficulty of
measuring dissociation constants of low affine interactions. Significantly, there was no binding between
AMP and a fully double-stranded RNA fragment, where each G in the overhang had C to bind to. Thus,
the binding of AMP was indeed specific to the overhang.
The question to answer next is whether the AMP-activated amino acids would bind to the overhang
with an enhanced affinity in case of the overhang matching the codon/anticodon of the tested amino acid.
The expectation is that the AMP part of the AMP-activated amino acid would serve as a guide for an
amino acid, bringing it close to the overhang. Then the amino acid, by interacting with the overhang,
could enhance the affinity of the aa-AMP binding.
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The results of this project provide a starting point for different screening approaches in order to test
whether the prebiotically plausible amino acids have an intrinsic affinity towards their cognate codons/
anticodons. This idea is the main thesis of the stereochemical theory of the origin of the genetic code.
For such tests, two components are of utmost importance: the RNA structures and activated amino acids.
One type of a stable activated amino acid, produced in experiments mimicking prebiotic Earth con-
ditions, is known from the works of the laboratory of Clemens Richert [36]. They obtain activated amino
acids, where an amino acid is attached to the AMP via its N-end and not via its C-end as in the aaRS
reaction center. Activated amino acids in the experiments of Richert’s group form directly in EDC-driven
polymerization reactions starting from mixtures of amino acids, RNA monomers, and short RNA strands
A way to stabilize an AMP-activated amino acid molecule, where an amino acid is attached to AMP
in a canonic orientation via its C-end, is to exchange the oxygen atom that bridges an AMP moiety and
an amino acid with either CH2 or NH. CH2 substitution is likely to result in a very stable activated amino
acid analog. However, two hydrogen atoms could result in a substantial steric hindrance when binding
to RNA motifs. Thus, the O to NH substitution is preferred. The synthesis protocol for activated amino
acids with an N-acyl phosphoramidate linkage is known from literature [58].
For the case of using the AMP-binding RNA aptamer as a testbed for affinity correlations, the follow-
ing general directions could be explored. First of all, a high-throughput screening has to be conducted.
For this, aptamers with codon/ anticodon sequences corresponding to the prebiotically plausible amino
acids should be synthesized. Synthesizing each aptamer with a fluorescent label is expensive. Thus, an
aptamer with an elongated 3′- or 5′-end should be synthesized, to which a short labeled oligonucleotide
can stably bind, enabling fluorescent labeling of all the aptamers with just a single labeled RNA strand.
Analysis of the available crystal structure of AMP in the aptamer’s binding pocket [13] can foster
the use of the aptamer as a testbed for affinity interactions. For example, in figure 21, the aptamer is
shown with AMP (in grey) and Val-AMP from Richert’s group (purple) aligned such that the adenine
part of Val-AMP maximally overlaps with the adenine of AMP co-crystallized with the aptamer. Such
an overlap was chosen because the aptamer builds interactions with the adenine part and it is expected
that Val-AMP would also be stabilized in the binding pocket via a similar adenine binding.
For some preliminary analysis, I highlighted in turquoise the bases essential for AMP binding. These
are the bases that shouldn’t be modified in the screening procedure. The bases in dark blue are the bases
unimportant for AMP binding and they were the ones modified in the preliminary tests presented in this
Thesis. However, these bases are positioned quite far away from the amino acid part of the Val-AMP. The
question arises whether the aa-AMP can “flip” inside the binding pocket, using the flexible link between
the ribose and adenine, such that the amino acid part comes into closer contact with the bases highlighted
in the dark blue color. Since I saw significant modulations in the dissociation constant depending on the
presence of the amino acid moiety (Figure 18), the expectation is that these bases could affect the binding.
On the other hand, the bases highlighted in pink are not important for AMP binding. They are
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Figure 21: AMP and Val-AMP in the binding pocket of the AMP-binding RNA aptamer.
The crystal structure of the AMP-binding RNA aptamer with AMP (grey) in the binding pocket (PDB:
1raw) and Val-AMP (purple) aligned such that the adenine moieties of the two molecules are maximally
overlapping. In turquoise are the bases essential for AMP-binding. In dark blue are the bases modified
to Val codon sequence in the preliminary tests. In pink are the bases in close proximity to the Val part of
the Val-AMP.
building the double stranded region of the aptamer that probably gives stability to the binding pocket. A
possibility to modify the bases in this region to match codon/ anticodon sequences can also be explored,
as this region is in close proximity to the amino acid part of the Val-AMP without any “flipping” involved.
Though the tests of the Rodin’s hypothesis with AMP and amino acids were so far negative, one
should explore the possibility that aa-AMPs could show preferential binding to stems containing codon/
anticodon sequences. The Hopfield’s pre-tRNA structure showed binding to AMP, albeit with low affin-
ity. That makes it a promising instrument for checking whether the affinity could be enhanced when the
cognate amino acid is attached to AMP.
Another possibility for the experimental setting is to test binding of the discussed structures to small
polypeptides rather than to individual amino acids. Richert’s work shows that polypeptides are readily
formed when the first amino acid is capture by AMP via its N-end [28]. Thus, AMP-polypeptides could
be prebiotically plausible substrate for early translation mechanisms.
One should also not forget to test different buffer conditions, mono- and divalent ions dependence,
temperature dependence, and other environmental parameters.
A fascinating outlook for the project would be to test a library of RNA sequences forming potentially
enzymatic tetraloop-like structures of the Rodin’s or Hopfield’s type [82] for aminoacylation activity
starting with aa-AMP substrates. The plausibility that small RNA structures can support aminoacylation
reactions is based on the work by Yarus’s group, where they isolated a 5-nt long ribozyme capable of
trans-phenylalanylating a partially complementary 4-nt long substrate on its terminal 2’-ribose hydroxyl
[91]. Moreover, the sequence of two bases - GU - that shows catalytic activity within the 5-nt long
sequence of the ribozyme was found to show aminoacylation activity also within a structure of a long
complex ribosomal RNA strand [35].
SELEX experiments for the aminoacylation activity should be combined with their quantitative anal-
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ysis with next-generation sequencing platforms. A big advantage of this combination is that by stopping
the reaction at different time points, also the kinetics data could be obtained. Using different amino acids
and comparing the resulting structures, a common motif may emerge.
In summary, in this part of the Thesis, I tried to establish various models for testing the stereochemi-
cal theory of the origin of the genetic code. The models range between the pre-tRNA structures suggested
in literature to simply using an aptamer that can bind AMP and, thus, could bind aa-AMP - an important
intermediate in aminoacylation reaction. Only the preliminary proof-of-principle experiments were per-
formed to show the feasibility of the approach to measure affinities directly between the activated amino
acids and RNA structures with MST as the method of choice. A wide variety of experiments could be
conducted from this point on to advance the project to the next stages. Hopefully, in a long term, new
experimentally proven patterns of amino acids’ associations with their cognate codons/ anticodons could
be shown to strengthen or disprove the stereochemical theory of the origin of the genetic code.
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Quantitative analysis of protease 
recognition by inhibitors in plasma 
using microscale thermophoresis
T. Dau1,*, E. V. Edeleva2,3,*, S. A. I. Seidel2, R. A. Stockley4, D. Braun2 & D. E. Jenne1,5
High abundance proteins like protease inhibitors of plasma display a multitude of interactions 
in natural environments. Quantitative analysis of such interactions in vivo is essential to study 
diseases, but have not been forthcoming, as most methods cannot be directly applied in a complex 
biological environment. Here, we report a quantitative microscale thermophoresis assay capable of 
deciphering functional deviations from in vitro inhibition data by combining concentration and affinity 
measurements. We obtained stable measurement signals for the substrate-like interaction of the 
disease relevant inhibitor α-1-antitrypsin (AAT) Z-variant with catalytically inactive elastase. The signal 
differentiates between healthy and sick AAT-deficient individuals suggesting that affinity between AAT 
and elastase is strongly modulated by so-far overlooked additional binding partners from the plasma.
One of the fundamental regulatory mechanisms in cell biology is the finely tuned interaction between enzymes 
and their substrates1. Binding between an enzyme and a substrate is most likely strongly influenced by the com-
position of the biological buffer system, for example by various plasma components2. However, functional assess-
ment of protein-protein interactions in native environments has been a major challenge to date3,4.
Immunoassays and surface plasmon resonance are the current standard approaches to quantitate concentra-
tions in plasma and to determine affinities of potential known targets5,6. However, both methods require surface 
immobilization of an antigen or an antibody, potentially imposing steric hindrance and molecular activity prob-
lems. Immobilization-free approaches based on fluorescence resonance energy transfer (FRET) require availabil-
ity and labeling of both interacting partners7,8. Therefore, FRET-based methods cannot determine the affinity of 
a person-specific endogenous protein to a known target of interest in a plasma sample.
Microscale thermophoresis (MST) is a recently established immobilization-free affinity measurement tech-
nique that has been applied to characterize ligand-binder interactions and affinity constants ranging from pM to 
mM under challenging conditions9–11. MST employs the physical phenomenon of thermophoresis – movement 
of molecules in a temperature gradient. Biomolecules tend to move against the temperature gradient causing the 
depletion of a biomolecule in the heated spot. In the MST binding measurement, the depletion of the fluores-
cently labeled binder changes upon ligand binding. Measurement of depletion at increasing ligand concentrations 
results in a binding curve, which can be used to derive the affinity.
In our previous work using an MST-based approach, we showed how the affinity as well as the concentration 
of the ligand can potentially be determined in complex matrices such as blood serum12. The first limitation of this 
method is the sensitivity as only an additionally spiked but not initially present ligand could be detected in serum. 
Secondly, low affinity interactions remain a challenge, as they often require unrealizable high concentrations of 
the unlabeled binder to establish a complete binding curve.
An important clinically relevant example of protein interactions in plasma is the inhibition of the enzyme neu-
trophil elastase (NE) by α -1-antitrypsin (AAT). Low plasma levels of AAT predispose to emphysema and chronic 
obstructive pulmonary disease13,14. Decreased AAT levels are often caused by the relatively common Z-mutation 
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Figure 1. Dependency of the amplitude on the AAT concentration and the dissociation constant of NE-AAT  
binding. (a) Describes the theoretical background of the method. At each data point, the inhibitor I1 (here: 
AAT) competes with I2 (here: elafin) for the enzyme E (here: labeled inactive NE). The affinity between E and 
I2 is much higher than the affinity between E and I1. (b) To a constant amount of plasma (7.5%) containing 
I1 and a constant amount of E (500 pM) increasing concentrations of I2 were added and the thermophoretic 
depletion measured. Titration curves with theoretical fits are given for three individuals (patients 1, 8 and 10) 
as examples in (b). All individuals were homozygous for the Z-variant AAT. Each depletion value is given as 
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(Glu342Lys)15 which accounts for 95% of patients with clinically relevant manifestations. Although all individu-
als with the Z-mutation have reduced AAT levels, development of lung emphysema is highly variable among ZZ 
carriers and some are minimally affected13,14,16.
The interaction between NE and AAT has been well studied in vitro using the two purified interacting proteins 
in standard buffers17. AAT inhibits NE irreversibly in a two-step reaction18. The first and rate-determining step 
is the formation of a reversible encounter complex between NE and AAT, where AAT mimics a substrate19,20. 
Previous approaches focused only on the concentration of AAT5,13,15,16, although kinetically efficient formation of 
this encounter complex also depends on the dissociation constant between NE and AAT19,20.
In this work, we developed a novel assay that overcomes the limitations of the previous approaches and 
allowed us to characterize the formation of the NE-AAT encounter complex at the given AAT level of a blood 
plasma sample under constant equilibrium conditions.
Results
Method development: combining concentration and affinity. In our assay, a low affinity inhibitor 
I1 (here: AAT) competes with a high affinity inhibitor I2 (here: elafin) for a catalytically inactive labeled enzyme 
E (here: NE) (Fig. 1a). Inactivation of E was important to prevent the removal of I1 from the equilibrium by the 
irreversible formation of a covalent complex, thereby allowing us to analyze the encounter reaction in the plasma 
environment.
The labeled E at a fixed final concentration of 500 pM was mixed with 12-fold diluted plasma containing the 
analyte I1. To obtain binding curves, increasing amounts of I2 were then added and thermophoretic depletion of 
free E and E bound to I1 (EI1) or I2 (EI2) was measured for each concentration of I2 (Fig. 1a,b). We observed that 
the depletion in the low end range of I2 concentrations varied between plasma samples while the depletion in the 
high end range of I2 concentrations did not change (Fig. 1b).
To compare the binding curves, we introduced a normalized parameter, the thermophoretic amplitude, 
by calculating the difference between the depletion signals in these two I2 concentration ranges (Fig. 1b, 
Supplementary Information 1). We observed that the thermophoretic amplitude varied between plasma samples. 
We hypothesized that I1 concentrations and, more importantly, I1 affinities to E are not necessarily constant in the 
person-specific proteomic environment of plasma samples (Fig. 1b).
To characterize the system at different affinities between I1 and E (Fig. 1c) and different I1 concentrations 
(Fig. 1d), we described it with the mass action law equations and simulated the corresponding binding curves. 
The simulation results indicate that the thermophoretic amplitude increases with an increasing KD(EI1) (Fig. 1c 
small insertion graph) and decreases with increasing I1 concentrations (Fig. 1d small insertion graph). Hence, 
the thermophoretic amplitude reports on both I1 concentration and KD(EI1) (a detailed mathematical analysis is 
provided in the Supplementary Information 2).
Thermophoretic amplitude is better correlated with disease status. To evaluate whether the 
thermophoretic amplitude that includes affinity variations represents a better lung function parameter than AAT 
concentration alone, we determined both parameters in plasma samples of individuals homozygous for the AAT 
Z-variant. We then compared these to FEV1 (the forced expiratory volume in one second) expressed as the per-
centage (%) predicted for age, sex, height, and race, which is widely used to assess the level of airway obstruction 
and bronchoconstriction in AAT-deficient individuals16,21.
In order to avoid measuring the concentration of inactive AAT, we titrated the concentration of functional 
plasma AAT with purified and active site-titrated NE. We observed a significantly lower thermophoretic ampli-
tude (P = 0.0008) with plasma samples from individuals showing a high FEV1 (≥ 80%) than from those with 
low FEV1 (< 80%) (Fig. 2a), while the concentration of functional AAT did not differ between the two groups 
(P = 0.6368). Hence, inclusion of affinity with our method resulted in a much better relationship to disease status 
and severity. To explain the discrepancy between the two quantification methods, we reasoned that KD(EI1) of the 
Z-variant in fact varied in the plasma samples.
Z-variant AAT is sensitive to plasma environments. To investigate whether affinity is indeed sensi-
tive to a given plasma environment, we determined the KD(EI1) of the AAT Z-variant in the two AAT-deficient 
plasma pools from persons with high (≥ 80%) and low FEV1 (≤ 50%) values (Fig. 3). To facilitate the recombi-
nant production of the aggregation-prone Z-variant, we combined three stabilizing mutations derived from the 
work of Lee et al.22 – Met374Ile, Ser381Ala, Lys387Arg – and introduced them into the Z-variant. As a control, 
we expressed AAT without the Z-mutation but containing the same stabilizing mutations. The affinity of the 
Z-variant to NE was more than two times better in the plasma pool from individuals with high FEV1 (≥ 80%) 
(KD(EI1) = 500 ± 100 nM) than from individuals with low FEV1 (≤ 50%) (KD(EI1) = 1300 ± 250 nM), confirm-
ing the plasma-dependent change in the affinity between NE and Z-variant AAT as observed with our newly 
developed assay. Additionally, we found that the Z-mutation improves the encounter reaction of AAT with 
mean ± S.D. from three technical replicates. The amplitude is defined as the difference of minimal depletion 
signals in the low end range (dark grey box with arrow) and maximal depletion signals in the high end range 
of I2 concentrations (light grey box with arrow). The thermophoretic depletion of free E is smaller than that 
of E bound to I1 or I2, and depletion at each I2 concentration indicates the proportion of bound E. (c,d) Are 
simulations according to the mass action laws. (c) Shows that the theoretical amplitude (simulated as the 
amount of bound E) increases when the dissociation constant between E and I1 increases. (d) On the other 
hand, the theoretical amplitude decreases with the increasing concentrations of I1.
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NE (Supplementary Fig. 1a) and Z-variant AAT is more susceptible to plasma components than control AAT 
(Supplementary Fig. 1b).
Discussion
By incorporating a high affinity ligand in thermophoretic measurements, we expanded the spectrum of appli-
cations towards the low affinity range where e.g. enzyme-substrate interactions take place. This new approach 
allowed us to detect unexpected plasma-dependent interferences with AAT, suggesting that the functional capac-
ity of the Z-variant AAT is determined by the heterogeneity of other plasma components, which modulate the 
affinity of AAT towards target enzymes. For example, it was reported23,24 and has been confirmed by our group 
(unpublished) that lipoproteins bind to wildtype AAT, thereby influencing its inhibition of NE and thus could 
also affect the reactivity of the Z-variant in the plasma environment.
The analysis of the interaction between AAT and NE in plasma with our assay provides a possible expla-
nation of the variability in disease development in ZZ carriers. Normally, the reduced AAT plasma levels in 
Figure 2. Thermophoretic amplitude, but not plasma concentration of AAT is associated with disease 
severity. (a) ZZ-carriers (n = 26) were divided into two groups with high FEV1 (≥ 80%, n = 8) and low FEV1 
(< 80%, n = 18), which is a clinical parameter of airway obstruction. The thermophoretic amplitude was 
significantly lower (P = 0.0008) in samples with high FEV1 (***P < 0.001; ns not significant). The amplitude 
is given as a mean value determined from at least two independent experiments. (b) The concentration of 
functional AAT was not significantly different (P = 0.6368) between the groups with high FEV1 (≥ 80%) and low 
FEV1 (< 80%). The AAT concentration was measured twice by elastase titration in duplicates, and is given as a 
mean value here.
Figure 3. Plasma-dependent change in affinity of NE-AAT binding. We compared the affinity between AAT 
and NE in two pools of plasma from individuals with high FEV1 (≥ 80%, n = 8) and low FEV1 (≤ 50%,  
n = 12). The affinity between Z-variant of AAT and NE was higher in plasma with high FEV1 (≥ 80%) 
(KD(EI1) = 500 ± 100 nM) compared to low FEV1 (≤ 50%) (KD(EI1) = 1300 ± 250 nM). Presented binding 
curves represent example measurements where each measurement point (mean ± S.D.) was derived from three 
technical replicates. Fitted binding curves and KD(EI1) values (mean ± S.D.) were derived from global fitting 
of four measurements (three independent protein expressions). The measurements were performed in 7.5% 
plasma and with 5 nM of labeled NE.
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ZZ carriers are compensated by the enhanced affinity of Z-variant AAT to NE. However, the enhanced affinity 
between Z-variant AAT and NE can be disrupted by plasma factors, especially in individuals who have higher 
concentrations of interfering plasma components.
Our work underscores the importance of the endogenous personally unique and distinct environment where 
substrates interact with enzymes with relatively low affinity in a complex web of other proteins and lipid com-
ponents. Such personalized variations and effects have often been overlooked. Our approach may open a way to 
study how other components from the native environments interfere with biochemical reactions.
Methods
Production of recombinant proteins. As the natural Z-variant is on a M1(Ala213) background, we 
amplified a cDNA fragment encoding the M1(Ala213) variant using the primer DJ3689 (5′ -GACTTCCACG 
TGGACCAGGCGACCACCGTGAA-3′ ) and DJ3613 (5′ -GATGACCGGTTTTTTGGGTGGGATTCAC 
CACTT-3′ ) (cursive: restriction site; bold: mutation) and cloned it into the Pml I and Age I site of the previously 
described M1(Val213) AAT construct in pTT5 plasmid (Perera et al.25. To introduce the Z-mutation (Glu342Lys), 
a PCR fragment was generated with the primers DJ3557 (5′ -CCACGATATCATCACCAAGTTCCT-3′ ) and 
DJ3558 (5′ -GTATGGCCTCGAGGAACATGGCCCCAGCAGCTTCAGTCCCTTTCTTGTCGATGGT-3′ ) and 
inserted into the M1(Ala213) AAT pTT5 plasmid between the Eco RV and Abs I sites. The three stabilizing muta-
tions (M374I, S381A, K387R) were introduced by PCR using the following forward and backward primers DJ 3646 
(5′ - CACGATATCATCACCAAGTTCCTGGAAAATGAAGACAGAAGGTCTGCCGACTTACATTTACC-3′ ) 
and DJ3696 (5′ -ATGACCGGTTTTTTGGGTGGGATTCACCACTCTTCCCATGAAGAGGGGAGC CTTGGT 
ATTTTGTTCAATAATTAAG-3′ ) respectively. The product was inserted into the Eco RV and Age I sites.
To produce a catalytically inactive variant of NE, we mutated the Ser195 to Ala195 by inserting an oligo duplex 
(DJ3532 (5 ′  -GTGAACGTATGCACTCTGGTGCCACGTCGGCAGGCAGGCATCTGCT TCGG 
GGACGCT-3′ ) and DJ3533 (5′ -CGTCCCCGAAGCAGATGCCTGCCTGCCGACGTGGCACCAGAGTG 
CATACGTTCACAC-3′ )) into the Alf I site of the previously described wildtype mouse NE construct in pTT5 
(Dau et al.26. To enable site-specific labeling of NE, we added a C-terminal short peptide with a cysteine flanked by 
three aspartate residues on each side by the insertion of an oligoduplex (DJ3632 (5′ - CTAGCGACGACGATTG 
CGACGATG ATC-3′ ) and DJ3633 (5′ - CTAGGATCATCGTCGCAATCGTCGTCG-3′ )) into the Avr II site.
All proteins were expressed in HEK293 EBNA cells (Yves Durocher, National Research Council Canada, 
Montreal, Canada) in FreeStyleTM 293 expression medium (Thermo Fisher Scientific Inc.), 1% Pluronic and 
G418 (25 μ g ml−1) at 37 °C and 8% CO2.
Labelling of NE. First, we added 1 mM DTT to the recombinant NE in storage buffer (20 mM Na2HPO4, 
300 mM NaCl pH 7.4) and incubated it for two hours at room temperature to reduce all cysteine-tags. Then 
we removed DTT by precipitating NE with 75% ammonium sulfate. This reduction and precipitation step was 
repeated once. NE was dissolved in storage buffer and incubated at room temperature for one hour after adding a 
5-fold molar excess of dye (Alexa Fluor® 647 NHS Ester, ThermoFisher Scientific). To remove the excess dye, the 
solution was added to PD MiniTrap G-10 column (GE Healthcare) according to the manufacturers instruction.
Determination of AAT concentration in blood plasma. After titrating trypsin (Sigma-Aldrich, 
St. Louis) with 4-nitrophenyl 4-guanidinobenzoate (Sigma-Aldrich, St Louis, USA) in veronal buffer, AAT 
(Athens Research & Technology, Athens, GA, USA) was titrated against trypsin. A dilution series of AAT 
was incubated with a constant amount of trypsin at 37 °C for 1 hour. The residual activity was measured using 
Boc-Gln-GLy-Arg-AMC. Thereafter, a dilution series of the titrated AAT was incubated with a constant volume 
of active human NE (Elastin Products Company, Inc., Owensville) at 37 °C for 1 hour. The remaining activity was 
measured with MCA-GEAIPTSIPPEVK(Dnp)-rr (EMC microcollections, Tübingen, Germany). All reactions 
were performed in 150 mM NaCl, 50 mM Tris, 0.01% Triton-X-100, pH 7.4.
Active site titrated neutrophil elastase was added to a dilution series of plasma and incubated at 37 °C for 
1 hour. The plasma was diluted in 150 mM NaCl, 50 mM Tris, 0.01% Triton-X-100, pH 7.4. The residual activity 
was measured using MCA-GEAIPTSIPPEVK(Dnp)-rr (EMC microcollections, Tübingen, Germany).
Determination of the concentration of recombinant AAT. A dilution series of AAT-variants was 
incubated with 1.6 nM active site titrated human NE at 37 °C for 1 hour. The residual activity was measured using 
MCA-GEAIPTSIPPEVK(Dnp)-rr (EMC microcollections, Tübingen, Germany).
Statistical analysis. Results are given as median values. A Mann-Whitney test without assuming Gaussian 
distribution was applied to all studies (***P < 0.001). Statistical analyses were done with GraphPad Prism 6 soft-
ware (GraphPad Software).
Development of the Binding Model for Simulations. Mass action law equations with two dissociation 
constants were used to describe the dependency of free NE on the concentration of AAT and on the affinity of 
AAT to NE in the presence of two NE ligands – AAT and elafin.
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where
K I D1  – dissociation constant of NE – AAT interaction,
K I D2  – dissociation constant of NE – elafin interaction,
[E], [I1], [I2] – total concentrations of NE, AAT, and elafin in the reaction, respectively,
[EI1] – concentration of NE-AAT complex in the reaction,
[EI2] – concentration of NE-elafin complex in the reaction,
= +x EI EI
E
[ ] [ ]
[ ]
1 2  – fraction of occupied NE,
Equation (2) was solved for [E], which was then applied to equation (1) to yield a cubic equation for x. The cubic 
equation was solved numerically in Igor Pro 5.03 and the smallest real root of the equation was then used to plot 
the fraction of bound NE x against different elafin concentrations I2 to simulate binding curves.
Determination of the thermophoretic amplitude. Human recombinant elafin (Sigma-Aldrich) was 
serially diluted (1:1) over five orders of magnitude in PBS. Separately, plasma was diluted (final concentration: 
7.5%) with storage buffer substituted with 0.02% Tween 20 and anti-photobleaching enzyme and substrate com-
ponents (Monolith Anti Photobleach Kit, NanoTemper Technologies) were added. This plasma solution was 
mixed 1:1 with PBS for background measurements. After adding fluorescently labeled NE (final concentration: 
500 pM) to the plasma solution, we mixed this 1:1 with each concentration of the serial elafin dilution. The sam-
ples were loaded into the Monolith™ NT.115 premium coated capillaries (NanoTemper Technologies), and incu-
bated at 22 °C for 2 hours. The samples were measured in the instrument (Monolith NT.115Pico, NanoTemper 
Technologies) at 22 °C using 60% light-emitting diode and 40% infrared laser (IR) powers with IR laser on/off 
times of 25/5 seconds. Each dilution point was measured in triplicates. For each plasma sample, the whole proce-
dure was repeated three times to yield independent triplicates.
In Matlab R2014a (8.3.0.532), the time trace of the background signal was subtracted from the time traces 
of the sample signals. Then, the fluorescence after the temperature jump and equilibrated thermophoresis was 
normalized to the fluorescence before the IR laser heating yielding fluorescence depletion values. Fluorescence 
depletion values of three technical replicates (mean ± S.D.) were plotted in per mille units (‰) on a linear y-axis 
against the concentration of the serially diluted elafin on the log10 x-axis resulting in binding curves. The binding 
curves were shifted so that the depletion value at the baseline, where elafin concentration is saturating, was the 
same. In Igor Pro 5.03, a weighted fit to the quadratic solution of the mass action law was performed to yield the 
amplitude A of each curve:
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where
KD – dissociation constant of NE – elafin interaction,
[E] – total concentration of NE,
x – total concentration of elafin,
A – the amplitude of the curve,
t – y-offset of the curve,
with A, t, and KD as free fit parameters.
Determination of dissociation constant between AAT and NE. Freshly purified AAT was serially 
diluted (1:1) over five orders of magnitude in storage buffer. Separately, plasma was diluted in storage buffer 
substituted with 0.2% Tween 20 (final concentration: 7.5%) and anti-bleaching reagents were added. This plasma 
solution was mixed 1:1 with storage buffer for background measurements. Fluorescently labeled NE (final con-
centration: 5 nM) was added to the plasma solution and mixed 1:1 with the serial dilution of AAT. The samples 
were incubated at 22 °C for 2 hours and measured at 22 °C in the instrument using 40% light-emitting diode and 
40% infrared laser (IR) powers with IR laser on/off times of 20/5 seconds.
Binding curves were obtained as described for the determination of the thermophoretic amplitude. They were 
then additionally normalized to 0 at the lowest AAT concentration and to 1 at the highest AAT concentration. 
This corresponds to the proportion of bound NE at each titration point. The global fit of at least three replicates 
to the quadratic solution of the mass action law was performed to yield the dissociation constant of each curve.
Plasma samples. FEV1 was determined post bronchodilator treatment and according to the British Thoracic 
Society/Association of Respiratory Technicians and Physiologists (BTS/ARTP) guidelines as described previ-
ously21. All subjects provided written informed consent, and ethical approval was obtained for all aspects of this 
study (South Birmingham Research Ethics Committee LREC 3359).
References
1. Overall, C. M. & Blobel, C. P. In search of partners: linking extracellular proteases to substrates. Nat. Rev. Mol. Cell Biol. 8, 245–257 
(2007).
2. Adams, T. E. & Huntington, J. A. Thrombin-cofactor interactions: structural insights into regulatory mechanisms. Arterioscler. 
Thromb. Vasc. Biol. 26, 1738–1745 (2006).
www.nature.com/scientificreports/
7Scientific RepoRts | 6:35413 | DOI: 10.1038/srep35413
3. Syafrizayanti, Betzen, C., Hoheisel, J. D. & Kastelic, D. Methods for analyzing and quantifying protein-protein interaction. Expert 
Rev. Proteomics 11, 107–120 (2014).
4. Sinz, A. Investigation of protein-protein interactions in living cells by chemical crosslinking and mass spectrometry. Anal. Bioanal. 
Chem. 397, 3433–3440 (2010).
5. McElvaney, N. G. Diagnosing α 1-antitrypsin deficiency: how to improve the current algorithm. Eur. Respir. Rev. 24, 52–57 (2015).
6. Mariani, S. & Minunni, M. Surface plasmon resonance applications in clinical analysis. Anal. Bioanal. Chem. 406, 2303–2323 (2014).
7. Kraynov, V. S. et al. Localized Rac activation dynamics visualized in living cells. Science 290, 333–337 (2000).
8. Uhlik, M. T. et al. Rac-MEKK3-MKK3 scaffolding for p38 MAPK activation during hyperosmotic shock. Nat. Cell Biol. 5, 1104–1110 
(2003).
9. Wienken, C. J., Baaske, P., Rothbauer, U., Braun, D. & Duhr, S. Protein-binding assays in biological liquids using microscale 
thermophoresis. Nat. Commun. 1, 1–7 (2010).
10. Seidel, S. A. I. et al. Microscale thermophoresis quantifies biomolecular interactions under previously challenging conditions. 
Methods 59, 301–315 (2013).
11. Jerabek-Willemsen, M. et al. MicroScale Thermophoresis : Interaction analysis and beyond. J. Mol. Struct. 1077, 101–113 (2014).
12. Lippok, S. et al. Direct detection of antibody concentration and affinity in human serum using microscale thermophoresis. Anal. 
Chem. 84, 3523–3530 (2012).
13. Gooptu, B., Ekeowa, U. I. & Lomas, D. A. Mechanisms of emphysema in alpha1-antitrypsin deficiency: molecular and cellular 
insights. Eur. Respir. J. 34, 475–488 (2009).
14. Sun, Z. & Yang, P. Role of imbalance between neutrophil elastase and alpha 1-antitrypsin in cancer development and progression. 
Lancet. Oncol. 5, 182–190 (2004).
15. Hutchison, D. C. Natural history of alpha-1-protease inhibitor deficiency. Am. J. Med. 84, 3–12 (1988).
16. Stockley, R. A. & Turner, A. M. α -1-Antitrypsin deficiency: clinical variability, assessment, and treatment. Trends Mol. Med. 20, 
105–115 (2014).
17. Dobó, J. & Gettins, P. G. W. alpha1-Proteinase inhibitor forms initial non-covalent and final covalent complexes with elastase 
analogously to other serpin-proteinase pairs, suggesting a common mechanism of inhibition. J. Biol. Chem. 279, 9264–9269 (2004).
18. Potempa, J., Korzus, E. & Travis, J. The serpin superfamily of proteinase inhibitors: structure, function, and regulation. J. Biol. Chem. 
269, 15957–15960 (1994).
19. Kang, U. B. et al. Kinetic mechanism of protease inhibition by alpha-1-antitrypsin. Biochem. Biophys. Res. Commun. 323, 409–415 
(2004).
20. Gettins, P. G. W. Serpin structure, mechanism, and function. Chem. Rev. 102, 4751–4804 (2002).
21. Guidelines for the measurement of respiratory function. Recommendations of the British Thoracic Society and the Association of 
Respiratory Technicians and Physiologists. Respir. Med. 88, 165–194 (1994).
22. Lee, K. N., Park, S. D. & Yu, M. H. Probing the native strain iin alpha1-antitrypsin. Nat. Struct. Biol. 3, 497–500 (1996).
23. Gordon, S. M. et al. Rosuvastatin alters the proteome of high density lipoproteins: Generation of alpha-1-antitrypsin enriched 
particles with anti-inflammatory properties. Mol. Cell. Proteomics 14, 3247–3257 (2015).
24. Talmud, P. J. et al. Progression of atherosclerosis is associated with variation in the alpha1-antitrypsin gene. Arterioscler. Thromb. 
Vasc. Biol. 23, 644–649 (2003).
25. Perera, N. C. et al. NSP4 is stored in azurophil granules and released by activated neutrophils as active endoprotease with restricted 
specificity. J. Immunol. 191, 2700–2707 (2013).
26. Dau, T., Sarker, R. S. J., Yildirim, a. O., Eickelberg, O. & Jenne, D. E. Autoprocessing of neutrophil elastase near its active site reduces 
the efficiency of natural and synthetic elastase inhibitors. Nat. Commun. 6, 6722 (2015).
Acknowledgements
This work was supported by a joint grant (JE194/4-1 and BR 2152/2-1) of the Deutsche Forschungsgemeinschaft. 
This project has received funding from the European Union’s Horizon 2020 research and innovation programme 
under grant agreement No. 668036 (RELENT). E.E.V. is supported by a DFG Fellowship through the Graduate 
School of Quantitative Biosciences Munich (QBM).
Author Contributions
T.D., E.V.E. and S.A.I.S. designed and performed the experiments. D.E.J. and D.B. supervised the project. R.A.S. 
provided plasma samples and clinical data. All authors discussed the results and implications and commented on 
the manuscript at all stages.
Additional Information
Supplementary information accompanies this paper at http://www.nature.com/srep
Competing financial interests: The authors declare no competing financial interests.
How to cite this article: Dau, T. et al. Quantitative analysis of protease recognition by inhibitors in plasma using 
microscale thermophoresis. Sci. Rep. 6, 35413; doi: 10.1038/srep35413 (2016).
This work is licensed under a Creative Commons Attribution 4.0 International License. The images 
or other third party material in this article are included in the article’s Creative Commons license, 
unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, 
users will need to obtain permission from the license holder to reproduce the material. To view a copy of this 
license, visit http://creativecommons.org/licenses/by/4.0/
 
© The Author(s) 2016
